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Abstract 
The present research focuses on the development of a novel silk fibroin based 3D artificial 
nanofibrous structure for its usage as a scaffold in bone tissue engineering. Silk fibroin (SF) was 
extracted from eri and tasar silk cocoons by degumming method and a spinnable SF blend was 
developed by selection of an optimal binary solvent system i.e. chloroform and formic acid 
(60:40 w/v). Randomly oriented nanofibrous scaffolds were developed from SF blend by 
electrospinning. The morphological characteristics of the developed scaffolds were studied by 
SEM, TEM and AFM. The structural and thermal properties were investigated by XRD, FT-IR, 
TGA, DSC and TM-DSC. The scaffolds were also characterized for surface property (% water 
uptake and contact angle measurement) and mechanical property. In vitro cell culture study 
confirmed the excellent cell supportive property of the scaffold in terms of cell attachment, cell 
proliferation and cellular metabolic activity using hMSCs derived from umbilical cord blood. 
The scaffold possessed good osteogenic property as confirmed by ALP, biomineralization, 
osteocalcein and RUN X 2 expression. All these results suggest that the developed SF blend 
derived from eri and tasar can be used as a base polymeric scaffold material for tissue 
engineering application including bone tissue regeneration.  
Surface property and osteogenic differentiation ability of the nanofibrous SF blend scaffold were 
further improved by the deposition of nanohydroxyapatite (nHAp) over the surface of the 
scaffold by surface precipitation method and thus, SF/nHAp composite scaffold was developed. 
Similar to SF blend scaffold, the composite scaffold was also characterized for surface, 
mechanical and biological property and the results were compared with that obtained with pure 
SF blend scaffold. It was demonstrated that the developed composite scaffold showed improved 
surface property and osteogenic differentiation ability as compared to SF blend as well as the 
widely used SF scaffold derived from Bombyx mori. Hence, it can be concluded that the 
developed SF/nHAp nanostructure is a promising scaffold in bone tissue engineering application. 
Keywords: Bone tissue engineering, silk fibroin, hydroxyapatite, scaffold, polymer composite, 
eri silk, tasar silk, electrospinning 
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1.1 Background and significance of study 
It is a well-known fact that millions of people are suffering from various tissue related diseases 
including bone tissue diseases and defects arising from trauma, injury, congenital and 
degenerative bone loss and pathologic conditions [1]. Currently, 1 million bone grafting 
procedures are performed only in U.S. every year with a growth of 13% per year. Loss of human 
lives is very alarming owing to the shortage of organ donors. Keeping this in view, bone tissue 
engineering has emerged as the most promising technique for repairing diseased and/or damaged 
bone tissues by developing biological substitutes that enable complete recovery of original state 
and tissue functions [2]. It has also been considered that the design and fabrication of a 
biologically active artificial extracellular matrix (ECM) is one of the most challenging tasks in 
bone tissue engineering. Scaffold must be biocompatible and have desired degradation rate, high 
mechanical strength, high porosity and the required resistance to foreign body reactions [3]. In 
addition, scaffold should also provide the required structural support to host bone cells and 
facilitate bone formation by stimulating cell adhesion, proliferation and finally regulate 
osteogenic differentiation of host cells [4]. In this context, material properties and appropriate 
fabrication technique are prerequisites for the development of 3D scaffold for bone tissue 
regeneration. 
The component of natural bone matrix is the combination of organic and inorganic materials and 
a variety of proteins, the main type of which is collagen and apatite as biological minerals. To 
meet the above requirement, a lot of research interest has been generated in recent years to 
explore potential biopolymers and their composites that can be used as scaffold materials in bone 
tissue regeneration. Though a variety of biopolymers have already been used for scaffold 
development in bone tissue engineering, not a single candidate is so far available commercially 
that can meet all the desirable properties required for scaffold development. As the structural 
characteristics of scaffold can’t exactly mimic ECM, the mat of the scaffold didn’t recapitulate 
the microenvironment for proper proliferation, differentiation and neo tissue formulation. 
Recently, artificial ECM made from polymer nanofibers has been considered as the most 
important features for tissue regeneration. Besides the amplified available surface area, 
nanofibers resemble with body tissue mimicking ECM to a greater extent. In this context, 
electrospinning is reported to be a promising technique for various tissue engineering 
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applications. Hence, there is a strong and urgent need of a research program for the development 
of a novel scaffold material and the fabrication of a 3D nanofibrous structure using appropriate 
technology to mimic the unique hierarchical architecture of bone matrix. 
1.2 Tissue engineering in regenerative medicine  
Tissue engineering and regenerative medicine is an interdisciplinary field where new materials 
are added to heal and regenerate damaged body parts day by day. The study of structure-function 
relationship in both normal and pathological tissues has been coupled with the development of 
biologically active substitutes or engineered materials. Bone is a hard tissue and the present 
healing procedure through tissue engineering requires material properties complying with its 
specification. The National Science Foundation of U.S. has identified its significant importance 
and defined it as “Tissue Engineering is the application of principles and methods of engineering 
and the life sciences towards the fundamental understanding of structure/function relationships in 
normal and pathological mammalian tissues and the development of biological substitutes to 
restore maintain or improve functions" [5]. The final goal is to develop new therapies that are 
impossible to treat successfully with existing medical approaches.  
Tissue formation and regeneration process occur in human body throughout life i.e. from 
embryogenesis to wound closure. This process consists of cellular migration, proliferation and 
extracellular matrix deposition [6]. Matrix deposition and its organization are very significant for 
new tissue development. Tissue formation is a two-step process: 1
st
 phase is often associated 
with migration of epithelial cells and ECM deposition while the later phase is associated with 
matrix remodeling and transformation of initial granulation tissue to connective tissue [7, 8]. The 
derived material for scaffold fabrication depends upon polymers that can be replicated in 
nanofibrillar network with modulated interaction with multiple biochemical-ECM derived 
signals. The guidance should facilitate restoration of structure and function of damaged or 
dysfunctional tissue through a provisional 3D matrix which control the cellular function with 
guidance to spatial and temporal complex multicellular processes for tissue formation and 
regeneration. The properties of material and design of scaffold should encounter rejection by our 
body (skin, blood, bone, etc.) [9]. 
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Tissue construct preparation with merging of engineered biomaterial with stem cell technology 
opens a new era for wound healing. Certain properties such as: porosity, pore size distribution, 
mechanical strength and rate of degradation are required to be tailored based on the type of tissue 
required to be regenerated. Artificial 3D matrices called scaffolds provide the structural integrity 
similar to the natural extracellular matrix (ECM) in the body utilizing bioinert and tissue friendly 
material. Gradually, this idea is shifted from bioinert to bioactive while maintaining the same 
physical function, durability with enhanced surface biointegration. Emphasis has been given to 
provide various tissue specific function to construct while compromising certain 
physicochemical properties of the implant till it participate in tissue regeneration processes. This 
can be feasible through implantation of stem cells within scaffold.  
In contrast, the regeneration of scarry tissue in lieu of functional tissue is of no use. Thus, the 
classic 'triad' of Tissue Engineering is based on the three basic tissue components: a scaffold on 
which cells are incorporated and signals provided to build and differentiate the tissue. 
1.3 Tissue engineering scaffold as ECM 
1.3.1 Scaffold and its properties 
It is advantageous to design scaffold by taking guidance and inspiration from ECM. Thus, 
scaffold acts as a carrier of viable cells and function as a provisional ECM during regeneration 
[10], comply with practical handling of grafts and implants and thereby, synthesize the 
functional tissues. The role of various properties in defining its suitability for tissue regeneration 
has been given in Table 1.1. 
1.3.2 Biomaterials for scaffold development 
Metals, ceramics and polymers are generally used in tissue engineered constructs to replace the 
damaged body parts. Their use depends upon the type and location of tissue to be regenerated. 
Metals lack degradability while ceramics raise certain issues related to mechanical stability in 
addition to biodegradability. 
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Table 1.1: Properties of Scaffold 
Property Description 
Porosity  Should have large volume fraction to facilitate nutrient diffusion and allows 
cell migration. It should not be large enough to provide sufficient binding 
site for cell adhesion. 
Mechanical 
properties  
 
Elastic modulus should match with the target tissue to avoid shear stress 
and fibrotic encapsulation formation while enduring tensile stress, 
compression and other forces at the site of implantation. It should be finely 
tuned for lineage specific differentiation [11]. 
Degradability  
 
Degradation rate should be equal to rate of new tissue formation without 
toxic byproduct. Further, it should not be solubilized during tissue 
regeneration processes. 
Surface chemistry Either promotes or prevents protein adsorption and cell attachment. 
Surface 
topography 
Compelling for cell adhesion and tissue integration via mechanical and 
integrin mediated interlocking. 
Biocompatibility Material and its degraded products should be non-toxic, non-immunogenic 
and lack of geno-toxicity. 
Bioactivity Material should induce tissue synthesis (intrinsic property). Certain ligands 
such as RGD, YSIGR provide bioactive property to scaffold. 
Specific tissue 
inducing properties 
The scaffold should promote cell adhesion, proliferation and migration as 
well as differentiation of particular phenotypic tissue as desired e.g. 
osteoconductivity and osteoinductivity in case of bone [12]. 
Other properties Structurally reinforce the defect, prevent ingress of surrounding tissue and 
act as a delivery vehicle for cells, GF and genes [13]. Further, controlled 
release of growth factors is essential for tissue development. 
 
1.3.2.1 Polymers 
Polymeric implants can be designed as hard or soft, rigid or elastic, inert or bioactive and 
degradable or non-degradable as per demand. The versatility of polymer finds a replacement for 
metals and ceramics [15]. Non-degradable polymers are required for electric cord in a pace 
maker, patches and intraocular lenses [16]. However, tissue engineering construct focuses on 
biodegradable polymer with non-toxic byproducts due to their replacement by body tissue. The 
degradation of material into non-toxic in vivo by-product is important for tissue regeneration 
[17]. Synthetic polymers such as poly(glycolic acid), poly(lactic acid), poly(ethylene glycol) and 
poly(vinyl alcohol) can be used for formation of functional biomimetic structure and extensively 
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explored for cellular compatibility. Knitted structures developed from these provide large 
specific surface area for cell adhesion and give enough space for cells to grow and develop an 
ECM environment.  
Synthetic polymers 
These are synthesized chemically so that it is possible to control the degradation rate and 
stiffness by varying its number of branching, polymerization and molecular weight. Additionally, 
they can withstand a range of processing techniques involving high temperature and pressure 
those are not possible in case of natural polymers. They can produce scaffold with complex 
architecture which is not possible for natural polymers. In contrast, cells do not recognize 
synthetic polymer surfaces. Cell integrin fails to bind the scaffold surface. Moreover, some 
synthetic polymers are non-degradable while others have cytotoxic degraded product. 
Natural polymers 
Natural biopolymers used for tissue engineering include collagen, polyhydroxy butyrate, 
chitosan, gelatin, fibronectin, hyaluronic acids and silk fibroin (SF). Collagen is found in body 
tissues such as teeth or bones, cartilage, skin, blood vessel and even muscles. The diversity of 
source affords different structure, function and molecular characteristics of extracted collagen. 
Since this is intimately related to the matrix components in all tissues, they are most promising 
polymer for regenerative and repair. Fibrin, a biodegradable protein takes part in provisional 
matrix formation after tissue damage that will be later replaced by cellular activity. This fibrous 
matrix is used for anchoring skin grafts. Curie et al. has found that presence of fibronectin 
enhance cell migration within the fibrin matrix [18]. Chitin, poly(β-(1-4)-N-acetyl-d-
glucosamine), a natural biopolymer is synthesized by an enormous number of living  organisms 
such as arthropods (exoskeleton) fungi and yeast (cell wall). Chitosan is the most important 
derivative of chitin obtained by (partial) deacetylation of chitin in the solid state under alkaline 
conditions (concentrated NaOH) or by enzymatic hydrolysis. Chitin and chitosan are 
biocompatible, biodegradable and non-toxic polymers. These properties make it application in 
tissue engineering, wound healing and drug delivery. Nevertheless, these biopolymers are 
endowed with poor mechanical properties and fail to meet the requirement for bone tissue 
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regeneration. The search for a new material with high tensile strength finally terminates with silk 
whose mechanical properties can with stand the desired strength and stiffness suitable for bone. 
1.3.2.2 Bioceramics 
Bioceramics such as β-Tri Calcium Phosphate, Octa Calcium Phosphate, Hydroxyapatite (HAp) 
are widely used in bone tissue engineering application. HAp is the major constituent of bone 
(nearly 75%) of dry weight and responsible for much stiffness and strength of scaffold. They are 
biocompatible, osteoinductive, bioactive and have unique capacity for bone binding with low 
degradation rate. The bioactive glass because of the presence of silicate (-O-Si-O-) network 
promotes the nucleation of natural HAp which is desired for bone tissue engineering. However, 
these materials are often associated with brittleness and thereby, limiting their applications. 
1.3.2.3 Biopolymer and its composites 
For high strength application, synthetic polymer, biopolymers and their composites with 
derivatives of calcium phosphate have been developed. However, most of the fabrication 
techniques involve synthetic polymer based application. Laurecin and his co-workers have 
developed composite PLGA/HAp via combination of emulsion freeze drying [29]. 
1.4 Scaffold fabrication techniques 
A number of scaffold fabrication techniques have been evolved for the development of tissue 
engineering scaffold, a brief of these techniques are introduced here. 
1.4.1 Salt leaching  
Salt leaching is a simple, convenient and cost effective method to introduce porosity into tissue 
engineering scaffold [19]. These processes involve casting of a polymer-porogen solution 
followed by solvent evaporation and removal of porogen by solvent washing. Porogens for this 
method include sodium chloride, paraffin spheres, sugar crystals, gelatin and polymers. 
However, this method fails to produce controlled pore size (submicron and nanoscale), 
interconnectivity and irregular pore geometry. Ma et al. fabricated paraffin spheres of different 
sizes by changing the concentration of gelatin which is very effective to disperse paraffin liquids 
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to form spherical droplets. PLLA scaffold can be prepared through this method using paraffin 
spheres and PLLA/1,4-Dioxane solution [20].  
1.4.2 Freeze drying 
Freeze drying is used to produce porous open cell materials where the pore microstructure is 
controlled by a removable phase that is distributed in 3D space termed as removable template. 
The scaffold material is allowed to distribute around the removable template which is removed 
thereafter. The process includes an aqueous/organic solvent based solution of polymer which is 
solidified at atmospheric pressure to a specified final freezing temperature in a mold determining 
final geometry of scaffold. During solidification, the polymer content is localized between the 
growing ice crystals in aqueous phase. The process completion emerges with continuous 
interpenetrating network of ice crystals surrounded by polymer network. Application of very low 
pressure (Psub) through a vacuum pump removes the ice phase with minimum effect on porous 
architecture of polymer network. The pore size and morphology are generally influenced by final 
freezing temperature (Tf) and heat transfer processes. The rate of nucleation (ice crystal 
formation) and diffusion are mediated by degree of undercooling required to initiate 
solidification [21]. 
1.4.3 Electrospinning 
The architecture of the biomaterial is of great importance. Indeed, it must mimic the morphology 
of the tissues (i.e. the bone and the subchondral bone) to promote cell adhesion, growth, 
migration and differentiation. Successful tissue regeneration requires the development of a three-
dimensional nanofibrous scaffold, which displays a large specific surface and a high porosity 
with appropriate pore size. Recently the very promising elaboration of nanoscaled (~50 nm) 
fibrous scaffold has emerged with the development of electrospinning techniques [22]. The 
developed non-woven mat has a very large specific surface area and a multiscale pore size 
distribution from nano to micrometers making them excellent candidates for biomaterial 
scaffolds improving cell interactions. 
Electrospinning (first discovered in 1902 by Marley and Cooley) is the preparation of fiber from 
a polymer solution by applying an electrostatic field to a constant flow rate solution. It involves 
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pushing the solution through a syringe pump forming a Taylor cone on the tip. The electrostatic 
force generates a drawing force on the charged droplet to collect the produced fibers on the 
stationary grounded target [23]. In total 13 different parameters such as concentration of 
polymer, viscosity, surface tension, conductivity, volatility, applied voltage, tip-collector 
distance, flow rate, diameter of needle, temperature, humidity and air velocity of the chamber 
regulate the morphology of electrospun fibers. Besides these parameters, type of solvent system 
and nature of polymer decides the spinnability of polymer. Turning on the positive electrode 
from the voltage source attached to the metal tip of the syringe needle injects polar liquid jet. 
Increase in electric field strength creates repulsion in charged solution and the grounded plate 
creates tensile forces on the pendant drop to elongate generating fibers [24]. The random 
depositions of fibers on the ground target for several hours create a highly porous non-woven 
mat with standard deviation of fiber about 60-70%. Uneven jet stretching, possibly due to low 
polymer concentration creates fibers with beads. Continuous fiber formation happens if the jet 
does not undergo break up during elongation processes where elasticity of the solution act as 
restoring force. Elasticity is a function of molecular weight of polymer and solution viscosity 
while the other parameter surface tension is affected by the type of solvent and polymer 
concentration [25]. 
 
Figure 1.1: Schematic diagram of a typical electrospinning setup 
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Electrospinning is capable of producing micro/nanofibers from a list of synthetic and 
biopolymers too numerous to name. Biopolymers are of special interest in tissue engineering due 
to their complete removal after healing. The commonly used solvent include ethanol, methanol, 
HFIP, THF where choice depends on solubility, boiling point, and dielectric constant. Certain 
macromolecules fail to electrospun due to low molecular weight and high entanglement which 
require either a mixture of solvent or addition of co- polymer to produce nanofibers.    
The terminal fiber diameter can be projected mathematically by a scaling law and Deborah 
number correlation (De) to predict the density of beads [26,27]. The terminal fiber diameter is 
the minimum achievable fiber diameter under a certain set of fluid and electric field conditions. 
Balancing the attractive and repulsive forces along the fiber backbone, the equation of the 
terminal fiber diameter will be     
 
 
 
 
 
               
   
. Flow rate current ratio is 
fundamental scaling for electrospinning processes. The second term, surface tension (γ), 
dielectric constant (ε) and a dimensionless whipping term (χ) play a minor role. The Deborah 
number gives an insight into relaxation time of a solution relative to processing time scale. For a 
solution to electrospun, the processing time equates the rate of whipping. Yu and company finds 
that no fibers (droplets only) are produced for De< 1 across all values of viscosity and surface 
tension force while De> 6 generates uniform fibers. De between 1-6 creates beads on string 
morphology.  
1.4.4 Rapid prototyping 
Rapid prototyping (RP), generally known as solid freeform fabrication (SFF) is a set of advanced 
manufacturing processes in which objects can be built by layer by layer deposition manner 
directly from computer data such as Computer Aided Design (CAD), Computed Tomography 
(CT) and Magnetic Resonance Imaging (MRI). The ability to incorporate advanced RP and CAD 
techniques to produce scaffold is now a mature application area of RP. The fabrication starts 
with a 3D design which is transferred into a STL (stereolithography) file format where thin 
virtual, horizontal cross sectional slices are transferred layer by layer. This technique is based on 
extrusion-based RP techniques, 3 Dimensional Printing (3DP), Selective Laser Sintering (SLS), 
Stereolithography (SL), Microstereolithograph (µSL) and Electron Beam Melting (EBM). 
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1.5 Stem cells for tissue engineering 
Hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) [28,29] are endowed with 
multilineage differentiation potential and immunomodulatory properties. The HSCs possess 
immunomodulatory activity and promotes hematopoiesis. The major sources of MSCs include 
blood, bone marrow, adipose tissue, placenta, amniotic fluid, fetal tissue and umbilical cord 
blood (UCB). Among these, UCB is one of the potential sources for the isolation of MSCs and 
HSCs because of ample availability ease of handling and cheaper as being considered as hospital 
waste product. The failures to isolate and grow MSC from UCB in many cases raise questions 
regarding the presence of mesenchymal progenitors in full term UCB [30]. In fact the frequency 
of MSCs in UCB is very low and decline in fetal blood with gestational age from about 1/10
6
 to 
mononuclear cells in 1
st
 trimester of fetal blood to 0.3/10
6
 mononuclear cells in terms of cord 
blood [31]. Despite these limitations, isolation of CBhMSCs is possible through selection of 
critical parameters from processed cord blood units.   
1.6 Thesis organization 
The whole thesis work has been arranged in the following chapters. Chapter 1 describes the 
general introduction including background and significance of scaffold materials and its 
properties, fabrication techniques and organization of the thesis. Chapter 2 provides literature 
review on different varieties of Indian silk, a SF based scaffolds for bone tissue engineering, 
scaffold properties, and surface modification those have been performed till now. Chapter 3 
defines scope and objective of the study. Chapter 4 describes the materials and detailed 
methodology adopted throughout the research work. Chapter 5 describes results and discussion 
consisting of 3 parts that includes (i) preparation of SF blend solution (ii) development of 
electrospun nanofibrous SF blend scaffold (iii) development of SF/nHAp composite scaffold. 
Chapter 6 provides summary and conclusion. 
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Bone defects and diseases are increasingly becoming alarming worldwide due to the crisis of 
organ shortage. To overcome the shortage of donor and a long waiting list of patient with bone 
tissue defects, there is need for an effective and alternative therapeutic strategy. In this context, 
bone tissue has emerged as the alternative strategy to repair and replace bone tissue. Bone is 
considered as the 2
nd
 most transplanted tissue in the world and there is great demand for 
treatment of bone tissue grafts [32], constructs and substitutes [33]. Bone tissue engineering 
requires a 3D scaffold that mimics the porous structure and excellent matrices functions of bone. 
Appropriate design and fabrication of this scaffold from a suitable material is a key challenge. 
Natural biopolymers and their composites through addition of ceramic materials are considered 
as the most attractive option for bone tissue regeneration [34, 35]. Polymer composites are 
combinations of two or more components usually containing an inorganic phase and a polymer 
phase that are essentially insoluble in each other [36]. Polymers have typically lower modulus 
and deformation resistance than the inorganic phase. Hence, attempts are made to adjust the 
mechanical properties of polymeric materials to approximate those of bone, using a composite 
structure. In fact, the matrix polymer containing filling components result in a complicated 
interaction between the properties of every constituent phase i.e. (a) the matrix (b) filling 
components and (c) the interfacial region between the filling components and the matrix polymer 
[37]. In the development of composites for bone tissue engineering scaffolds, two main 
approaches are being followed; the first approach considers the incorporation of bioceramic 
particles as inclusions into polymer structures e.g. foams, the second approach considers the 
incorporation of polymer coatings onto a 3D porous bioceramic [38].  
In bone tissue, ECM consists of an organic phase made of type I and type III collagen and 
glycosaminoglycans (GAGs) and an inorganic phase made up of nanohydroxyapatite (nHAp). 
Calcium Phosphate (CaP) nanoparticles can be introduced into polymer-based scaffolds such as 
acid-soluble chitosan [39], alginate [40] and some soluble collagens. Alternatively, chemical 
deposition processes using calcium salts and phosphate or phosphoric acid can produce nano-
featured CaP structures under controlled conditions. For example, flowing feed solution 
containing both calcium and phosphate ions has also been used to prepare collagen fibrils with 
CaP incorporated within the fibrils [41]. Studies have shown composite scaffolds of chitosan 
with HA and gelatin improves the biological responses of osteoblast cell type [42]. In another 
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study, authors found a decreased degradation rate and increased mineralization in SBF in 
composite scaffolds in the presence of nHAp [43].  
CaP including HAp, tricalcium phosphate (TCP) and calcium phosphate cements (CPC) play an 
important role in the development of scaffolds for bone tissue engineering. Porous CaP ceramics 
with interconnected macropores (>200 μm) and microporosity (~5 μm) as well as high porosities 
(~ 80%) have been produced by firing polyurethane (PU) foams coated with calcium phosphate 
cement at 1200
0
C [44]. The open micropores of the struts were infiltrated with poly(lactic-co-
glycolic acid) (PLGA) to achieve an interpenetrating bioactive ceramic/biodegradable polymer 
composite structure. Miao et al. [45] have also developed highly porous HAp/TCP composite 
scaffolds (87% porosity) infiltrated with PLGA to form ceramic-polymer interpenetrating 
microstructures. In these composites the addition of PLGA led to a significant improvement of 
the compressive strength. In related investigations, HAp scaffolds have been coated with HAp 
particles and polycaprolactone (PCL) [46]. The PCL matrix acted also as carrier for the antibiotic 
drug tetracycline hydrochloride. Chen et al. [47] have developed Bioglass®-based scaffolds 
coated with PDLLA. It was found that the bioactivity of scaffolds upon immersion in simulated 
body fluid (SBF) was not impaired by the PDLLA coating. Polyhydroxyalkanoate (P(3HB) has 
been investigated in parallel investigations as an alternative coating material for tissue 
engineering scaffolds [48]. Bretcanu et al [49] used bacteria-derived P(3HB) to infiltrate 45S5 
Bioglass® glass-ceramic scaffolds to enhance the work of fracture of the coated scaffold with 
respect to bare bioglass scaffold. Porous sponge scaffolds are suitable for bone tissue formation, 
as they enhance cell attachment, proliferation and migration. In addition, the high porosity (92-
98%) facilitates nutrient and waste transport into and out of the scaffolds. It was found that the 
lamellar architecture of silk based scaffold induced increased alkaline phosphatase activity and 
demonstrated higher equilibrium modulus than the spherical-pore scaffolds [49]. 
With the advances of nanotechnology, material design can be exploited into the nanometer scale- 
and nano-structured biomaterials begin to emerge [50]. Among them nanofibrous biomaterials 
are exciting because of their similarity to ECM structure and functionality [51]. The collagen like 
fibrillar structure of the nanofibrous biomaterials along with their high surface to volume ratio 
enhance cell adhesion which in turn improves cell migration, proliferation and differentiated 
function on these biomaterials [52, 53]. Nanofibrous scaffolds have been shown to have better 
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cell attachment than solid walled scaffolds due to more cell adhesion proteins absorbance. 
Osteoblasts were cultured on both nanofibrous and solid-walled PLLA scaffolds and cells on 
nanofibrous scaffolds showed higher alkaline phosphatase (ALP) activity and an earlier and 
enhanced gene expression of the osteoblast phenotype [54]. 
Electrospinning generates connected 3D mats with high porosity and high surface area that can 
mimic ECM structure and are suitable for tissue engineering applications [24]. It also produces 
non-woven meshes containing fibers with diameters ranging from tens of microns to tens of 
nanometers. Fibrous scaffolds have a high surface-to-volume ratio that enhances cell adhesion. 
[51] Electrospinning is used to fabricate nanofibrous structures from natural and synthetic 
polymers such as collagen (Col), gelatin, chitosan, SF, poly(DL-lactide-co-glycolide), 
poly(lactide), polyurethane, polycaprolactone, etc. with a mean diameter down to 5 nm. 
PCL/HA, PCL/Col/HA, PCL/Gel/HA, poly-L-lactic acid (PLLA)/Col/HA and poly(3-hydroxy-
butyrate-co-3-hydroxyvalerate (PHBV)/HA were fabricated by various research groups as a 
substitute for bone tissue engineering [55-59]. 
Tissue engineering approaches for bone repair with different morphology using SF have been 
reported. Initial effort starts with SF hydrogel [60] and membrane without cell seeding for 
guided bone tissue regeneration. Later on, in the last decade the regenerated SF was used as films 
[61]. SF based hydrogel has shown better in vivo bone growth than commercially available 
synthetic polymer [60]. In order to regenerate the complex defect at bone injury sites, several 
smaller scaffolds should be stalked instead of a large sized scaffold. Though large sized bones 
provide better mechanical strength, the mass transport limitation finds difficulty in its use [62]. 
Silk microparticles reinforced macroporous silk protein-protein composite scaffold was reported 
elsewhere [63]. Both the scaffold stiffness and bioactivities of composite scaffold was found to 
be enhanced on addition of silk microparticles to porous silk matrix. 3D porous scaffold with 
90% porosity prepared from regenerated SF derived from Bombyx mori with average pore 
diameter 50 μm were suitable for tissue regeneration [64]. Further improvement of this SF 
scaffold prepared from salt leaching produced scaffold with porosity 84-98% and average pore 
diameter 200 μm [65]. Yan et al. has improvised the physicochemical properties of SF based 
scaffold by tailoring the 3D architecture through a combined salt leaching and freeze-drying 
method for its use in cartilage and meniscus tissue engineering [66]. Mandal et al. developed 
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micron-sized silk fibers (10-600 μm) through alkali hydrolysis for fabricating reinforced compact 
fiber composite with tunable compressive strength, surface roughness, and porosity for bone 
tissue regeneration [67]. The inter connectivity of the pore of the scaffold is also an important 
factor in aiding nutrient transport, promoting cellular migration, cellular bridging and in growth 
of bone tissue [68]. The continuity of fiber and its orientation control the transmission of shear 
stress along the fibers upon exertion of biomechanical forces [69]. The stiffness of the scaffold 
also depends on the porosity and architectural design of the scaffold which ultimately decides the 
cell specific lineage of MSCs. Williams et al. also reported that the PLC scaffold fabricated by 
selective laser sintering resulted in varied stiffness values with change in pore diameter [70]. 
Furthermore, the stiffness of the material is reported to be altered by change in scaffold 
architecture [71]. The stiffness of the material has an influence on the differentiation of MSCs to 
a particular cell lineage. The values of stiffness that differentiate into bone specific lineage have 
been reported to be 30-34 kPa [72]. Bailey et.al has demonstrated the importance of gradient 
scaffold in cell-material interactions i.e. in the regeneration of the interfacial tissues (e.g. 
osteochondral tissues) [73]. Furthermore, Discher et al. have reported 5 times more susceptibility 
of MSC population to neural lineage whereas the bone specific lineage is 8 times more under 
same culture condition which is far behind critical requirement for in vivo use where 100% cells 
with desired lineages are mandatory to avoid any abnormal tumor formation [72]. 
The most extensively researched silks all over the world are those derived from silkworm silk B. 
mori and spider silk Nephila clavipes [74]. Silk is considered as an advanced biomaterial owing 
to its biocompatible and biodegradable property. It has much superior mechanical properties than 
the traditional synthetic polymeric materials used for tissue engineering applications. Silk is a 
protein biopolymer obtained from insects, spiders and silk worm. It is a combination of light 
weight (1.3 gm/cc), high strength (4.8 GPa) with outstanding toughness and elasticity [75]. It is 
thermally stable up to 250
0
C and hence can be processed for a wide range of temperature. 
Natural silk is composed of a filament core protein, SF and a glue-like coating consisting of a 
family of sericin proteins. The sericin is responsible for the inflammatory reaction in our body 
upon contact. SF from B. mori comprises of 12 repetitive crystalline regions and 11 non-
repetitive interspaced amorphous regions. It constitutes 45.9% glycine, 30.3% alanine, 12.1% 
serine, 5.3% tyrosine, 1.8% valine and 4.7% other remaining amino acids. However, it is 
insoluble in most solvents, including water, dilute acid or dilute alkaline solutions. Its elastic 
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modulus is in the range of 15-17 Gpa and tensile strength 610-690 MPa [76]. Rockwood et al. 
have demonstrated the use of B. mori SF as hydrogels, tubes, sponges, composites, fibers, 
microspheres and thin films implants for scaffolding in tissue engineering in vitro disease models 
and drug delivery [77]. 
For the first time Vollrath et al. have used spider silk for artificial spinning to produce fibers 
[78]. Lazaris et.al have utilized soluble recombinant spider silk produced in mammalian cell for 
biomedical application [79]. For the first time Sen et al. have demonstrated the structure and 
compositional variation of amino acid in different types of SF based on its source [80]. 
Nevertheless, impure SF is often associated with Type I allergic response because of 
upregulation of Immunoglobulin E (IgE) levels and thus aggravating asthma. There are 5 
different types of silk available in India that differs in their structure, property, composition and 
biological responses (Table 2.1). 
Table 2.1: Types of silk and their sources 
Sl no. Varieties of silk  Areas where found  
1 Mulberry Karnataka, AP, Tamil Nadu, J&K, Maharashtra, Mizoram, West 
Bengal, Uttarakhand, Assam 
2 Muga West Bengal, Assam, Meghalaya 
3 Eri Nagaland, UP, Assam, Orissa  
4 Tropical Tasar Chhattisgarh, Orissa  
5 Oak Tasar Manipur, Uttarakhand  
 
The production of Vanya silk in India (tasar, eri and muga) 2010-11 was reported to be 1166, 
2760 and 124 MT while in 2009-10 was 803, 2460 and 105 MT. Thus an increase of 45.2% 
tasar, 12.2% eri and 18.1% muga silk has been achieved. The production of mulberry silk nearly 
remained constant at 16322 MT in 2009-10 and 16360 MT in 2010-11. The difference of eri and 
tasar from mulberry type of SF in structure and functional properties were studied and their 
application in tissue regeneration has been reviewed for fabrication of a novel material with 
improved tissue regenerative property. In this context, the potential of eri and tasar silk for tissue 
regeneration as compared to SF from B. mori has been compared. These three types of SF are 
different from each other in their immunocompatibility, presence of RGD epitope, anti-bacterial 
Literature Review 
 
18 
 
and anti-inflammatory activity. Moreover, the regenerated SFs are highly heterogeneous in 
nature. The details of the structural heterogeneity is given in Table 2.2. Raghu et al. have shown 
that even 1% w/v of RSF shows structural heterogeneity. Therefore, their physicochemical and 
biological properties largely vary with respect to property modification and biological superiority 
[81].  
Table 2.2: Different types of silk and their structural difference 
Silk worm 
(species) 
Molecular 
weight 
(kDa) 
Type/size of 
polypeptide 
Amino acid 
Base/acid Hydrophobic
/hydrophilic 
Bulky/non-
bulky 
Mulberry 
(B. mori) 
440 Heterodimeric/H 
chain 390 L  chain 26 
0.65 0.28 0.17 
Non 
mulberry 
(P. ricini) 
400 Homodimeric/ H 
chain 230 
1.30 0.35 0.24 
Non 
mulberry 
(A. mylita) 
395 Homodimeric/ H 
chain 197 
0.97 0.44 0.34 
 
Stevens et al. have shown that ECM of our body consists of collagen nanofibers with diameters 
in the range of 50-500 nm [82]. Electrospinning of SF obtained from wild source remains a 
challenge due to its high content of bulky group containing amino acids and large degree of 
heterogeneity among the side chains. Ramakrishna and co. in his book have highlighted the role 
of various factors and types of materials that can be electrospun into fibers [83]. Meanwhile, 
Chen et al. have developed aqueous microfibrous SF scaffold for the first time with 34% w/v of 
SF [84]. In contrast, this failed to meet the natural architecture of body. For example, an all 
aqueous process for silk electrospinning was developed [85] after blending regenerated SF with a 
fiber forming agent, poly(ethylene oxide) (PEO) from 1:4 to 2:3 ratios to improve 
electrospinnability of silk solutions and to avoid the adverse effects of using strongly polar 
organic solvents such as hexafluoroacetone [86], hexafluoroisopropanol [87] and formic acid 
[88] on biocompatibility. A post-electrospinning treatment on SF fibers with methanol was then 
performed to induce a structurally conformational transition to the original β-sheet to render 
water insolubility in subsequent uses of the scaffold. Acidic protein poly(L-aspartate)(poly-Asp) 
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as a molecular recognition motif was first introduced into the electrospun SF fibers to enable 
subsequent nucleation and crystal growth of apatite on the fiber surface during mineralization. 
This approach is an alternative route for preparing composite nanofibers to avoid the 
electrospinnability problem encountered in the electrospinning of those HAp containing 
solutions which eventually leads to the formation of apatite-coated fibroin composite fibers, 
which is somewhat different from that obtained in the components hybridizing method [89, 90] 
and the nanostructure of hierarchical bone [91-93] in terms of distribution and morphology of the 
HAp nanocrystals in the composite fibers. Li et al. have found superior bioactive and 
biocompatibility properties of 3D porous scaffold developed from Antheraea pernyi as compared 
to B. mori scaffold [94]. Pal et al. revealed the superior potential of eri SF as compared to B. 
mori for tissue regeneration and calcium deposition [95]. 
Chen et al.showed that surface modification of B. mori scaffold with RGD has improved the cell 
adhesion property of MSCs and osteoblasts [96]. Sukigara et al. produced continuous electrospun 
nanofibers from B. mori through optimization of concentration, voltage and tip-collector distance 
[97]. Zhu et al. have demonstrated that reduction of concentration and pH of SF would transform 
the belt shaped nanofiber to cylindrical shape [98]. Fang et al. have verified the superiority of 
Antheraea pernyi SF over the SF derived from B. mori in preparation of the scaffold. Meinel et 
al. have fabricated beadless aqueous SF fiber by decreasing humidity in air [99]. Additionally, 
there are several other wild sources of silk varieties with difference in structure, amino acid 
composition such as muga and the crosslinked types. In general, the difference in content of 
hydrophilic amino acid sequence and presence of repeating units like RGD determine the 
superiority of one variety over the other. Structurally, SFs from these species are characterized as 
natural block copolymers composed of hydrophobic blocks with highly preserved repetitive 
sequence consisting of short side-chain amino acids such as glycine and alanine. Moreover, it 
contains hydrophilic blocks with more complex sequences that consists of larger side-chain 
amino acids as well as charged amino acids [80]. The hydrophobic blocks from β-sheets or 
crystals through hydrogen bonding and hydrophobic interactions, provide tensile strength of SF 
fibers [100]. Thus, the elasticity and toughness of silk is a function of ordered hydrophobic 
blocks in combination with less ordered hydrophilic blocks of SF [78]. The concentrated SF 
aqueous solution is a non-Newtonian liquid crystalline state, where SFs are lubricated and 
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stabilized by water and form micelle-like structures through phase separation due to SF’s 
intrinsic hydrophilic-hydrophobic block structure [74].  
Natural silk fibers are insoluble in polar solvents such as water, ethanol, dilute acids and bases, 
unless highly concentrated sulfuric acid, formic acid, hexafluoro isopropanol (HFIP), calcium 
nitrate or LiBr solutions are used [101]. Sirisuwan et al. have shown that eri silk is insoluble in 
most of the salt solutions having higher molecular weight which poses difficulty in preparation 
of regenerated SF solution [102]. SF combined with CaP based materials such as HAp, β-TCP or 
wollastonite would be able to produce composite scaffolds. In contrast, they fail to mimic the 
collagen-apatite composite which is naturally found in bone due to the lack of cell binding ligand 
RGD in its polymeric backbone. Jin et al. and Min et al. have reported that non-woven SF 
nanofibrous mats/nets support attachment, spreading and proliferation of human bone marrow 
stromal cells, keratinocytes and fibroblasts in vitro [85,103]. Moreover, random non-woven 
nanofibrous mats having diameter 150-300 nm fabricated by electrospinning also promote cell 
attachment, spreading, proliferation and differentiation of MC3T3-E1 osteoblast-like cells 
[104,105]. The above mats also have the potential for guided regeneration of bones at non-
weight bearing sites [106-108]. Kang et al. have improved bone tissue formation and 
mineralization through fibrin and hyaluronic acid surface coating which regulate the controlled 
release of BMP-2 [109]. These outcomes were in agreement with similar findings by Liu et.al. 
They have observed 14% and 25% improvement in bone tissue regeneration owing to surface 
coating of hyaluronic acid and BMP-2 over porous silicate glass [110]. Following this success, 
Li et al. recently developed silk-based composite nanofibers with the incorporation of HAp 
nanoparticles (approx. 5% w/v) and BMP-2 (3 µg/mg of silk fibroin) growth factor to realize 
enhanced bone formation outcomes from culturing human bone marrow-derived MSCs. They 
found that the inclusion of BMP-2 and HAp nanoparticles within electrospun SF fibers resulted 
in highest calcium deposition and upregulation of BMP-2 transcript levels, compared to other 
electrospun silk-based scaffolds including silk/PEO, silk/PEO extracted, silk/PEO/BMP-2 and 
silk/PEO/HA [89]. In another method, the inorganic apatite component was selectively grown on 
and associated with the electrospun fibrous SF matrix by subsequent mineralization after soaking 
in SBF [90]. Wei et al. have revealed the superiority of SF/nHAp nanocomposite prepared by 
direct mineralization in bone tissue engineering [94]. 
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Thus the chemical composition (material properties) of the scaffold material and its structural 
characteristics are prime factors that can affect cellular behavior and ultimately determine the 
performance of a tissue engineered construct [111]. The ideal standard for the purpose of human 
tissue regeneration is deemed to be the biopolymer or composite polymers that are endowed with 
a set of essential characteristics such as suitable surface chemistry, biocompatibility, gas 
permeability, biodegradability, mechanical strength, immunogenicity, foreign body response and 
so on [112]. It is further evident that a single biomaterial does not possess all the desired 
properties and thus there is need for the development of a polymer blend and/or composite 
material in appropriate composition from a variety of biopolymers and other biomaterials [113]. 
Failure of macroporous features of scaffolds to mimic the dimension scale of ECM rules out the 
reorganized cell microenvironment for proper proliferation, differentiation and neo tissue 
formation [114]. In this context, artificial ECM made from polymeric nanofibers because of its 
resemblance to body tissues has been considered as the most favorable feature for tissue 
regeneration [115]. Furthermore, among the biomaterials used for producing nanofibers, natural 
SF protein seems to be an attractive option [116]. These SFs are derived from both wild and 
domestic silkworms and spiders [117]. SF contains repetitive amino acid sequence of 
poly(alanine) or poly(gly-ala) type arranged in antiparallel β-sheet structure [118]. SF derived 
from these silks has robust mechanical strength, provides adequate stability in vitro and in-vivo, 
biocompatibility (sericine free) comparable to collagen I, less immunogenic and can be 
electrospun into pure SF nanofibers or blended with other biomaterials [118]. However, major 
drawback of the widely used SF derived from B. mori is low hydrophilicity and lack of natural 
cell binding domain RGD leading to poor cell attachment [119]. However, tasar and eri silks are 
more hydrophilic and possess the natural cell binding ligand RGD enthralling their attention in 
biomedical application. SF can sustain high temperature before degradation as evident from their 
thermal analysis study. Moreover, several literatures have reported the same way of sterilization 
and so we have used this method. There is very negligible effect of sterilization on degradation 
of scaffold with the release of few particles. Therefore we have performed consecutively two 
ways of sterilization i.e. autoclave followed by ethanol washing [120]. 
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In recent years, bone tissue engineering has emerged as a new but most promising technique for 
bone tissue regeneration. The major challenge of bone tissue engineering is the development of a 
biomimetic 3D scaffold from an ideal biopolymer or its composites. Among the several factors, 
material properties and structural features of a scaffold are the most important. In search of 
potential biopolymers, SF obtained from silk cocoon is found to have potential in bone tissue 
engineering because of its robust mechanical strength, desired biological and surface chemistry 
favoring bone tissue engineering applications of SF scaffolds. Furthermore, electrospinning has 
been considered as one of the most appropriate technique for the fabrication of a 3D scaffold. 
Therefore, the present research focuses on the development of a novel biomaterial or its 
composite and its fabrication of a 3D scaffold for bone tissue regeneration by electrospinning.  
The objectives of this thesis work are as follows:  
i. To prepare electrospun nanofibrous silk fibroin scaffolds for bone tissue engineering. 
ii. To improve the desired property of the scaffold by surface modification with a suitable 
bioactive molecule. 
iii. To study physicochemical, mechanical and biological properties of the scaffolds. 
iv. To investigate cell-scaffold interaction and osteogenic differentiation of hMSCs over SF 
scaffolds. 
Scope of work: 
It is evident that millions of people worldwide are facing acute problems of bone tissue diseases 
and defects arising out of accident, injury, degeneration and aging. The situation has increasingly 
become alarming due to shortage of donors. Though scaffold-based bone tissue engineering is a 
possible future clinical method to regenerate bone tissue, recovering disease or defect bone tissue 
functionality still faces many challenges. In this context, the main challenge is the design and 
fabrication of a 3D functional scaffold as artificial ECM from a suitable biopolymer or polymer 
composites by an appropriate method. Therefore, the main objective of this present work is the 
preparation of a novel silk based scaffold by electrospinning method.  
Various scope of the research work is enumerated as follows: 
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i. Development of a spinnable SF blend solution  
SFs derived from B. mori have been used as a potential biopolymer for the development 
of scaffold. However, they have lower hydrophilicity that limits their usage as cell 
supportive artificial ECM. In this project, efforts are given to explore the other silk 
varieties grown in India such as eri and tasar that have superior scaffold properties than 
B. mori. SF will be extracted from both the silks and a spinnable polymer solution will be 
developed by selecting a suitable solvent system. 
 
ii. Development of electrospun SF blend nanofibrous scaffold 
Among the types of scaffold, 3D nanostructured scaffold is the most essential feature 
regulating the vital cellular functions such as adhesion, proliferation and differentiation. 
In this context, electrospinning, a simple and straightforward method, will be used to 
fabricate electrospun nanofibrous scaffold from the spinnable eri-tasar SF blend. 
 
iii. Characterization of scaffold 
It is utmost important to appraise surface, mechanical and biological properties of the 
scaffold to find its suitability in bone tissue engineering. Properties of the scaffold such 
as morphology, roughness, hydrophilicity, porosity, tensile strength will be characterized. 
Cell supportive property in terms of cell adhesion, cell proliferation and cell 
differentiation potential will be evaluated. 
 
iv. Mechanism of biodegradation of scaffold 
It is essential to control the biodegradation of scaffold in order to match the rate of neo 
tissue regeneration. The structural and morphological changes upon biodegradation will 
be determined from FT-IR, XRD, TM-DSC, SEM and AFM analysis and finally, the 
mechanism will be elucidated. 
 
v. Improvement of osteogenic property of SF blend scaffold 
To make the developed nanofibrous SF blend scaffold more effective towards bone tissue 
formation there is need to further improve its osteogenic property. In this context, the 
deposition of nHAp may be beneficial. Therefore, direct mineralization method will be 
applied to precipitate nHAp over scaffold. Thus a novel SF/nHAp scaffold with improved 
osteogenic property will be developed to facilitate bone tissue regeneration. 
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4.1 Materials 
4.1.1 Collection and processing of silk cocoons 
Eri (Phylisomia ricini) and B. mori silk cocoons were collected from the local market of 
Mayurbhanj district and tasar (Antheraea mylitta) from Sundargarh district of Orissa, India. The 
collected eri and tasar silk cocoons were grounded into fine size and stored at -20
0
C in a sealed 
plastic bottle until further use. 
4.1.2 Chemicals and media  
Necessary chemicals such as calcium chloride (CaCl2) and sodium hydrogen phosphate 
(Na2HPO4) for the extraction of SF were obtained from Merck. Dulbecco’s modified eagle 
medium (DMEM), Penicillin-Streptomycin solution, fetal bovine serum (Hi-FBS), Dulbecco’s 
phosphate buffered saline (DPBS), chondrogenic basal medium and supplement, Collagenase 
type I and 0.25% Trypsin/EDTA solutions were obtained from Gibco (BRL, USA). Phalloidin-
Alexa Fluor 488 conjugate and calcein green AM were purchased from Invitrogen, USA. Ficoll 
Hypaque solution (Hi sep LSM 1073), osteogenic differentiation media, Giemsa 10x stain, 
Triton X-100, formaldehyde, MTT assay reagent, Commassie blue G-250 are from HiMedia 
labs, India. Growth factors EGF and bFGF, BD FACS lysis buffer, Propidium Iodide (PI), 
CD34-PE, CD29, CD44-FITC, CD45-PerCP/cy5.5, CD73-PE/APC, CD90-APC, CD105-PE and 
HLA-DR-PerCP/cy5.5 were purchased from Becton Dickenson, San Jose, CA. Dexamethasone, 
staurosporine, α-MEM, L-glutamine, L-ascorbate, β-glycerophosphate, protease XIV, bovine 
serum albumin (BSA), Oil red O, Alizarin red S, Safranin O, tris buffer were from Sigma-
Aldrich (St Louis, MO, USA). All the tissue culture plastic wares and RNAse were from BD 
falcon and MP Biomedicals, USA respectively. 
4.2 Methods 
4.2.1 Preparation of regenerated SF powder 
The chopped slices of cocoon were boiled in 0.02 M aq. sodium carbonate (Na2CO3) solution for 
30 min to remove sericin. This process is called degumming [121] and was repeated three times 
for tasar because of its higher sericin content. Extracted silk fibers were air dried and then 
dissolved in a ternary mixture of CaCl2/H2O/EtOH (1/8/2 mole ratio) for 40 min at 80
0
C. The 
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solution was dialyzed in a slide-A-Lyzer dialysis cassette (Pierce, Thermo fischer, MWCO 3500) 
against distilled water for 3 days at room temperature to remove salts. The SF solution thus 
obtained was filtered and concentrated against PEG 6000 MW and PEG 10,000 MW. The 
concentrated SF solution was frozen for 24 h in -20
0
C and lyophilized to obtain regenerated silk 
fibroin (RSF) powder. The prepared RSF powder was stored in vacuum desiccators until further 
use. 
 
Figure 4.1: Schematic diagram of the preparation of regenerated silk fibroin powder  
4.2.2 Preparation of eri-tasar SF blend  
Different batches of SF blends were prepared by dissolving the freeze dried SF powder of eri and 
tasar in a mixture of formic acid and chloroform (60:40 v/v) at room temperature while 
constantly stirring until a clear solution is formed.  
4.2.3 Preparation of SF blend nanofibrous scaffold by electrospinning 
3D nanofibrous mat from SF blend was prepared in electrospinning machine (PICO-ESPINO-
NANO, India) that consists of a 5 ml syringe with 0.55 mm needle diameter mounted on parallel 
plate geometry. The configuration of electrospinning machine is depicted in figure 1.1. Fiber was 
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formed at an applied electrostatic potential of 22 KV with a constant SF blend solution flow rate 
of 0.5 ml/h. Tip-collector distance was maintained at 15 cm. The fibers were collected on a 
grounded parallel plate collector consisting of aluminum sheet mounted over a glass plate.  
4.2.4 Preparation of gelatin nanofibrous scaffold by electrospinning 
Gelatin nanofibers were prepared by electrospinning following the previous literature [122]. In 
brief, 10% gelatin solution was prepared in formic acid while continuously stirring at room 
temperature for 1 h. The solution was filtered to remove insoluble fraction or impurities and then 
placed in a syringe (5 ml) with stainless steel syringe needle as an electrode. The syringe was 
connected to a syringe pump to control flow rate accurately. Electrospinning was performed at 
room temperature and at relative humidity about 65%. The applied electric potential was 
adjusted at about 20-21 kV and the distance to collector was between 12-15 cm for proper 
electrospinning. The produced non-woven mat of gelatin nanofibers was formed after few hours 
of running. Finally, it was dried overnight at 40
0
C in an oven to remove moisture before 
measurements. 
4.2.5 Preparation of SF nanofibrous scaffold from B. mori by electrospinning 
Electrospinning of SF derived from B. mori was carried out with a slight modification in 
electrospinning procedure followed by Sukigara and Co [104]. RSF obtained by lyophilization 
was used for preparation of 12% w/v solution in formic acid (98-100%). The silk-formic acid 
solution was placed in a 3 ml syringe (18 gauze). The tip-to-collection plate (covered with 
aluminum foil) distance was maintained between 12-13 cm; the plate placed vertically under the 
needle tip with flow rate of 1 ml/hr at room temperature in 65% relative humidity. The above 
process was carried out for 10-12 h to collect a thin mat of SF nanofibrous mat.  
4.2.6 Development of SF/HAp nanofibrous scaffold 
HAp was deposited on SF blend electrospun nanofibers by precipitation following the procedure 
described in literature [94] to prepare SF/nHAp nanocomposite scaffold. The nanofibrous 
scaffold was immersed in 0.5 M of CaCl2 solution in tris buffer for 12 h at pH 10.4. The scaffold 
was repeatedly washed with distilled water. Scaffolds were then immersed in 0.5 M of aq. 
Na2HPO4 solution in tris buffer for 12 h at pH 10.4 followed by washing with distilled water. 
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The alternate soaking and rinsing process were repeated for 3/5 cycles resulting in the 
precipitation of HAp over the nanofibers. The prepared HAp coated SF scaffold (SF/nHAp) was 
stored in a dessicator for further use.   
4.3 Characterization of scaffold 
4.3.1 Morphological characterization 
Scanning electron microscope (SEM) 
SEM (JEM2010, JEOL) was used to observe the morphology and fiber size of the electrospun 
nanofibrous scaffold. The nanofibrous scaffold were cut into small pieces and coated with 10 nm 
of platinum using a polaron range sputter coater before imaging. I individual fiber diameter was 
measured in the inbuilt imaging system and software attached to the instrument. The average 
diameter of fiber was determined by measuring 50 fibers selected randomly from each sample. 
Atomic force microscope (AFM) 
Topography or roughness of nanofiber scaffold surface was studied using a scanning probe 
microscope (VECCO) operated in AFM tapping mode at microscopic level (100-1 μm). In this 
technique, the probe tip made up of quartz is attached to a flexible micro-fabricated 225 μm long 
silicon cantilever with a spring constant of 3 N/m, the deflection of which is measured by optical 
method. The reflected light beam is focused to a particular position by moving the surface of the 
sample up and down and thus a constant force is maintained between the surfaces that produces 
topographical images. 
Transmission electron microscope (TEM) 
TEM images were obtained with a JEOL transmission electron microscope where the 
electrospun nanofibers were deposited on carbon-coated copper grids. The accelerated voltage 
was adjusted and the detailed shape and size of the nanofibers were examined. The study was 
carried out to find the shape of nanofibers, structural features of HAp crystals deposited over the 
nanofibers and the development of cell processes to confirm cell scaffold attachment. 
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4.3.2 Porosity and pore size distribution  
The distribution of pore diameter, total pore volume, and porosity of the electrospun nanofibrous 
silk fibroin  mat (approx. 0.8 mm thickness and 1x2 mm
2
) were measured using a mercury 
intrusion porosimeter (Autopore IV porosimeter, Micromeritics Instrument Co., Norcross,GA) in 
mercury intrusion under an increasing pressure from 0.5-2000 psi. Prior to mercury intrusion, the 
instrument was degassed to approximately 30 μm of Hg to remove all air from the system.  
Determination of porosity was based on the relationship between the applied pressure and the 
pore diameter into which mercury intrudes, according to the Washburn equation as  
P = - 2γcosθ/r 
where P is the applied pressure, r is pore radius, γ is the surface tension of mercury (484 mN/m) 
and θ is the contact angle between mercury and the pore wall taken as 1430 [123, 124].  
4.3.3 Structural analysis by XRD and FT-IR 
 X-ray diffraction (XRD) 
XRD curves were recorded in X-ray diffractometer (Rigaku D-Max B ) with an X’celerator 
counter at scanning rate of 0.040
0
/s with step size of 0.020
0
 within a scanning region of 2θ = 10-
80
0
 and CuKα radiation (λ= 0.1542 Å). The irradiation conditions were 30 kV and 30 mA. XRD 
patterns were analyzed in X’pert high score, Origin Pro 8 and JCPDS (joint committee on 
powder diffraction studies) softwares. Crystallinity of SF nanofibers and the variation in 
percentage of β-crystalline content due to enzymatic degradation were determined from this 
study. 
Fourier transform infrared spectroscopy (FT-IR) 
FT-IR (Automatic IR Microscope, AIM-800, SHIMADZU) was carried out to identify organic 
and inorganic compounds by determining the molecular composition and functional groups in SF 
blend. In FT-IR, scanning range, resolution and scan numbers were 4000-400 cm
-1
, 8 cm
-1
 and 
60 respectively. Approximately 1 mg of nanofibrous silk blend scaffold mixed with about 500 
mg of dry KBr powder was grounded using an agate mortar and pestle. The mixed powder was 
pressed into transparent disks with a diameter of 13 mm for the FT-IR work. 
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4.3.4 Thermal analysis by DSC, TGA and TM-DSC 
Differential scanning calorimetry (DSC) 
DSC determined the variation in glass transition temperature of enzymatically degraded SF 
scaffolds. DSC measurements were performed on a Mettler-Toledo 821 with intra cooler using 
STAR software. Temperature calibration and determination of the time constant of the 
instrument were performed by standards of In and Zn, and the heat flow calibration by In. 
Heating rate of 2
0
C min
-1
 was applied to scan the sample using standard aluminium pan and 
nitrogen gas was used to remove the volatiles from the samples.  
Thermogravimetric analysis (TGA) 
Thermal stability of samples was analyzed with TGA (Mettler-Toledo 821). Scaffolds were 
scanned from 30-400
0
C with a scanning rate 2
0
C/min to check thermal stability. Mass loss of the 
samples was determined with respect to increase in temperature to assess the thermal degradation 
behavior of the sample. 
Temperature modulated differential scanning calorimetry (TM-DSC) 
TM-DSC measurements were performed using Perkin Elmer DSC instruments, Pyris Diamond 
DSC system. The instrument was equipped with a refrigerated cooling system. The samples were 
heated at 2 K/min with a modulation period of 60 s and temperature amplitude of 0.5 K. This 
analysis was performed to separate glass transitions from relaxation or re-crystallization effects, 
melting processes, fast chemical reactions and for accurate determination of isothermal Cp. The 
above study was carried out to determine the mechanism of biodegradation of SF nanofibers. 
The equipment was equipped with software allowing the superimposition of a sinusoidal 
temperature fluctuation onto an underlying heating or cooling rate [125].  
4.3.5 Mechanical strength 
Ultimate tensile strength of the nanofibrous silk scaffolds were tested in Universal Testing 
Machine (Instron 3369, Bioplus) with a 1000 Newton load cell under standard atmospheric 
conditions at 65% relative humidity. Scaffold samples were cut into rectangular shapes (50x12 
mm) having thickness 0.30±0.01mm. The double sided glue tapes were used to stick the 
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scaffolds to the top and bottom clamps for positioning. The crosshead speed was 20 mm/min and 
the gauge length was 30 mm. The breaking strength and strain percentage of scaffolds were 
calculated from the stress strain plot.  
4.3.6 Swelling behavior  
The swelling studies of the nanofibrous scaffolds were performed in PBS and distilled water at 
pH 7.4 and 37
0
C. The dry weight of the scaffold was noted (wD). Scaffolds were then placed in 
PBS buffer at pH 7.4 for 1, 2, 3, 4, 5, 6, 7, 8, 24, 48 and 96 h. After this time period, scaffolds 
were removed, surface adsorbed water was removed by filter paper and the wet weight was 
recorded (wT). The swelling ratio and water uptake % were determined using equations 1 and 2 
[126].  
               
     
  
                            (1) 
              
     
  
                   (2) 
4.3.7 Contact angle measurement 
Wetting properties of the nanofibrous scaffolds were studied by dynamic contact angle 
measurements. Samples were fixed and a droplet of distilled water was applied to the surface. 
Water contact angles of the nanofibrous mat were measured by a contact angle goniometer 
(DSA-10, Kruss188, Germany). Images of each drop on the surfaces were recorded using a 
digital microscope. The contact angles were determined from the images using axisymetric drop 
shape analysis (ADSA-NA) methodology [127]. Mean values of the contact angles were 
calculated from five individual measurements taken at different locations on the substrates at 
25
0
C and 65% humidity. 
4.3.8 Bioactivity 
The SF nanofibrous scaffolds were immersed in 35 ml of SBF for 14 days at 37
0
C. SBF was 
prepared according to the literature [128] by adding NaCl (7.995 g), KCl (0.224 g), CaCl2.2H2O 
(0.368 g), MgCl2.6H2O (0.305 g), K2HPO4 (0.174 g), NaHCO3 (0.349 g) and Na2SO4.10H2O 
(0.161 g) to 1 L of distilled water in that order. The pH of the solution was then adjusted to 7.4 
by adding Tris/HCl. After soaking for a predetermined time period, these scaffolds were taken 
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out, rinsed with distilled water and blotted with tissue paper to remove excess moisture and then 
vacuum dried at 45
0
C for few hours. Morphological and elemental studies of the scaffolds were 
done by SEM and EDX respectively. 
4.3.9 Biodegradation 
SF has been reported to be degraded by several protease enzymes including protease XIV [129]. 
6×6×0.03 cm
3
 ethanol/propanol treated nanofibrous mats weighing 45±5 mg were incubated at 
37
0
C in 50 ml of PBS solution containing 0.23 U/ml protease XIV at pH 7.4. The nanofibrous 
mats without enzyme in PBS solution were treated as control. The retrieved samples were 
washed in distilled water after 0, 18 and 36 h, lyophilized and residual weight was measured. 
Morphological structure of the degraded SF nanofiber was observed using SEM. XRD, DSC and 
TM-DSC analysis of mat and their degraded products helped determine the mechanism. 
4.4 In vitro cell culture study  
4.4.1 Sources of MSCs 
MSCs isolated from umbilical cord blood (UCB), cultured in our stem cell culture laboratory 
were used for cell study. In brief, UCB was collected from the local Ispat General Hospital, 
Rourkela, India and mononuclear cells (MNCs) were isolated from UCB following Ficoll 
Hypaque method described in the literature [130]. The isolated MNCs were cultured  in DMEM 
supplemented with 10% fetal calf serum, 1% non-essential amino acid, 1% 200 mM L-
glutamine, 2% 1 M HEPES, 0.150 g/liter L-ascorbic acid, 100 U/ml penicillin and 0.1 mg/ml 
streptomycin. Culture condition was maintained at 37
0
C, 5% CO2 and 80% relative humidity. 
MSCs were separated based on their adherence to the culture flask and non-adherent cells were 
discarded. The adherent cells were washed thoroughly with D-PBS/EDTA and then 
supplemented with freshly prepared expansion medium. The cells were cultured in media 
changed weekly twice until the 4
th
 passaging. 
4.4.2 Culture of MSCs 
MSCs were sorted from the cultured MNCs by a florescence activated cell sorting (FACS ARIA 
III; BD Biosciences) using CD90-APC, CD73-APC, CD105-APC, CD44-FITC, CD45 PerCP 
Cy5-5, HLA-DR PerCP Cy5-5, CD34 PE (all are BD Pharmingen, San Jose, CA make). CD44, 
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CD90, CD73 and CD105 were used as positive markers. The sorted MSCs were further cultured 
in DMEM media changed twice in a week.  
4.4.3 Cell seeding and culture 
Non-woven nanofibrous SF mats of radius 0.6 cm
2
 were steam sterilized followed by ethanol 
washing [120] and then subjected to sterile PBS for ethanol removal. MSCs of passage four at 
the concentration of 5×10
4
 cells/cm
2
 were seeded into nanofibrous mats by static method. Cell 
seeded scaffold was incubated at 37
0
C in 5% CO2 and cultured in 2 ml of cell culture medium 
without growth factor following the procedure previously described [131]. The culture medium 
was replaced at regular intervals of 3 days. Cell suspension containing 5×10
5
 cells/ml in medium 
without scaffold was used as control (n=2).  
4.4.4 Cell morphology and cell attachment 
The cultured MSCs seeded on the scaffolds were fixed with 3.7% formaldehyde (Sigma) for 20 
min. The samples were diluted in blocking buffer at room temperature and permeabilized for 10 
min with 0.5% Triton X-100/PBS. Cells were incubated in DPBS solution after permeabilization. 
Samples were blocked for 30 min with non-specific binding of antibody and the 
immunocomplexes were detected by ALEXA 488 conjugated phalloidin (1:200). The nuclei 
were stained with 0.1 μg/ml of DAPI in PBS for 1 min. Then the cell-scaffold constructs were 
visualized under confocal laser scanning microscope to assess cell attachment. Morphology and 
spreading of MSCs over the scaffolds were analyzed by SEM within the first 72 h of cell 
seeding.  
4.4.5 Cell viability 
Fluorescent Microscopy  
SF nanofibrous mat of 0.5×0.5×0.03 cm
3
 were punched through a biopsy punch (Miltex) and 
sterilized by autoclave. The samples were then seeded with cells and cultured for desired period 
in a 96 well plate. They were then taken on a clean microscopic slide, mounted with 
glycerol:PBS (1:1 ratio) and observed under an upright fluorescence microscope (Carl Zeiss E600, 
wavelength 450 nm) using a green filter (wavelength 490 nm). These constructs were observed 
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for visualizing the interaction between cell and scaffold, subsequently the images were captured 
using Carl Zeiss Axiocam camera attached to the microscope.  
MTT assay 
Cellular metabolic activity of MSCs seeded on scaffolds were evaluated by 3, 4, 4, HEPES [5-
dimethylthi¬azol-2-y1]-2,5-diphenyl tetrazolium bromide (MTT) (Sigma, St. Louis, Mo.) 
staining. After 3, 5 and 7 days of culture, the cell seeded mats were incubated in MTT solution 
(0.5 mg/ml, 37
0
C, 5% CO2) for 2 h following the protocol in the published literature [132]. 
Intense pink colored formazan derivatives formed were dissolved and the absorbance was 
measured at 595 nm using spectrophotometric microplate reader (Perkin Elmer Model 2030 
Explorer). 
4.4.6 Cell proliferation 
SEM 
Qualitative determination of cellular proliferation was observed under SEM after 7 and 14 days 
of culture using the procedure described below. Prior to SEM analysis, cell-seeded scaffolds 
were rinsed in DPBS buffer and fixed with 2.5% glutaraldehyde in DPBS overnight at 4
0
C. The 
constructs were dehydrated by exposure to a gradient series of alcohol (50-90% gradient of 
alcohol in water followed by aseptic critical point drying and coated with platinum before 
observing under JEOL JSM-840A SEM. 
DNA content measurement  
Proliferation of cord blood-derived MSCs on SF blend scaffold was determined by DNA 
quantification using spectrophotometric microplate reader (Model Perkin Elmer 2030 explorer) 
[133]. For this purpose, scaffolds (6 beads/well) were placed in triplicates in 6-well tissue culture 
plate containing MSCs suspended (2×10
5
 cell/mL) in DMEM. The plates were incubated for 3 
and 5 days in a CO2 incubator at 37
0
C and 5% CO2. Total cellular DNA from cell-scaffold 
construct was isolated using alkaline lysis method. DNA content extracted was measured by 
spectrophotometric microplate reader at an absorbance of 260 nm for both the samples. To 
visualize MSCs on scaffold, the cells were seeded at 5×10
4
 cells/disk (5 mm diameter) density 
and cultured in DMEM with 10% FBS at 37
0
C for 3 days. The unattached cells were washed 
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away in PBS and the attached cells were fixed in 4% formaldehyde in PBS. Cells were treated 
with 0.2% Triton-X 100 (Sigma T9284) in PBS and blocked in 2% denatured BSA and were 
analyzed under inverted microscope.  
Alamar blue assay 
Proliferation of MSCs on the scaffolds was assessed for 7, 14, 21 and 28 days of culture using 
Alamar blue assay [14, 15]. This assay is based on the color change of fluorescence via 
oxidation-reduction reaction taken place in growth medium. After incubation, the scaffolds were 
placed in fresh wells in phenol red-free serum-free medium and then Alamar Blue was added 
followed by overnight incubation. After pipetting the media, OD was measured in a microplate 
reader at 570 nm. 
4.4.7 Cell adhesion  
4.4.7.1 Cell attachment 
The nanofibrous scaffolds were seeded with 2×10
5
 cells. Cell attachment was observed through 
phylloidin cytoskeleton staining counterstained with DAPI. This was further quantified by 
determining the average number of attached cells from 10 randomly chosen microscopic fields of 
observation at indicated time points. Data was plotted in graphs and compared with other 
scaffolds. 
4.4.7.2 Cytoskeleton analysis 
After an hour of culturing, MSCs seeded constructs (n=2 each) were rinsed in 1× PBS and 
prefixed in 0.5% glutaraldehyde in 0.1 M sodium cacodylate buffer [134]. The samples were 
added to the cell suspension in 1:1 ratio (n=2) and centrifuged. Pelleted cells were resuspended 
in 0.1 M sodium cacodylate buffer and added to 2% melted agar. The samples were then cooled 
and centrifuged at 300 g for 10 min. All samples were then rinsed in 0.1 M sodium phosphate 
buffer containing 1% OsO4 and dehydrated in gradient ethanol (10-50%) followed by the 
addition of 100% acetone. Samples were molded in a mixture of Spurr resin and acetone, and 
then polymerized at room temperature until complete hardening. Ultrathin sections of 100 nm 
size were cut with a diamond knife and stained with methanolic uranyl acetate followed by lead 
citrate. Thin sections were examined in a JEM-1200 EX II transmission electron microscope 
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(JEOL, MA, USA) at 6.0-7.5k magnification for entire cells and cell processes were visualized at 
30-33k magnification. 
4.4.7.3 CD44 and integrin beta 1 
Immunofluorescence measurement 
The cell-seeded scaffolds were cultured for 12 h and then fixed in 10% ice-cooled 
paraformaldehyde. The sections were blocked in 2% BSA before incubating with mouse anti-
CD44 (mouse1gG anti-rat 1:200), or mouse anti-CD29 (mouse1gG anti-rat 1:200) monoclonal 
primary antibodies. After incubation with primary antibodies, the sections were washed and 
exposed to Alexa-Fluon 488 and phycoerythrin conjugated secondary antibodies for CD44 and 
CD29 respectively. Fluorescent images were obtained using laser scanning confocal microscope 
(Leica, microsystem). DNA was visualized with Hoechst 33342 [134]. 
Flow cytometry analysis 
The cell adhesion property of the developed scaffolds were further quantified by analyzing the 
expression of CD44 and CD29 surface markers using flow cytometer (Fortessa, BD Bioscience, 
USA) by following the procedure described [135]. Cell-seeded constructs were trypsinized and 
washed in PBS after 12 h of culture. The detached cell concentration was adjusted to 1×10
6
 
cells/ml by the addition of ice cooled PBS. Then CD44 and CD29 surface markers conjugated 
with FITC and PE were added to the cell suspension and analyzed for CD expressions in flow 
cytometry.  
4.4.8 Osteogenic differentiation potential 
4.4.8.1 Alkaline phosphatase assay 
ALP activities of MSCs in constructs were measured to appraise the osteogenic differentiation 
potential as per the procedure described [136]. The constructs were cultured for 1, 7, 14 and 21 
days in osteogenic differentiation media. Then they were removed from the culture media and 
repeatedly washed in PBS. The cells were treated with 1% Triton X-100 (Fisher Scientific) for 
60 min and centrifuged at 10,000 rpm at 4
0
C for 15 min. 0.5 ml of supernatant was added to 
dilute p-nitro phenyl phosphate (100 μl of p-NPP concentrate per 2 ml of 100 mM sodium 
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bicarbonate/carbonate buffer, pH 10) and incubated at 37
0
C for 45 min. Reaction was stopped by 
adding 50 µl of 1 N NaOH and the absorbance of the mixture was measured at 405 nm. 
4.4.8.2 Glycosaminoglycan (GAG) estimation 
MSCs seeded scaffolds were grown in 96 well plates in osteogenic differentiation media for 3, 7, 
14 and 21 days with media changed every 2-3 days. The amount of extracellular GAG secreted 
into the media was analyzed using 1,9-dimethylmethylene blue in a microplate reader [137]. 
Similarly, intracellular GAG was removed from the cells by digestion with papain digestion 
solution (125 μg/mL of papain, 5 mM L-cystein, 100 mM Na2HPO4, 5 mM EDTA) at pH 6.8, 
60
0
C for 16 h and analyzed in microplate reader. Finally, the absorbance of GAG-DMMB 
complexes was measured at 525 nm. In order to avoid the variation in scaffold size and cell 
numbers, GAG contents were normalized against total scaffold weight and cell numbers. 
4.4.8.3 Biomineralization  
Biomineralization study was performed following the protocol in the literature [128]. The 
hMSC-seeded scaffolds were washed in PBS, fixed with glutaraldehyde dehydrated by ethanol 
gradient (a series of ethanol water mixture (10-50% ethanol), sputter coated with platinum and 
attached to the sample holder through a conductive carbon tape. Energy dispersive X-ray 
analysis was performed to detect the presence of Ca and P, their quantity and ratio in the 
analyzed sample. Cells were grown over the nanofibers deposited over carbon grid and analyzed 
by high resolution TEM after dehydration through a series of gradient ethanol. The samples were 
put into the chamber for observing the formation of HAp crystals over the nanofibers. 
Alizarin red assay  
Mineralization of hMSCs on the nanofibrous scaffolds was observed and quantified using 
alizarin red assay [138]. MSCs grown on scaffolds were washed in PBS and fixed with 
paraformaldehyde for 15 min. Cell-seeded scaffolds were thoroughly washed in distilled water 
and 500 mL of 40 mM alizarin red stain (pH 4.1) was added. The samples were then incubated at 
room temperature for 20 min with gentle shake. Unincorporated dyes were aspirated and the 
wells were washed thoroughly. Plates were then kept at an angle for 5 min to remove excess 
water, reaspirated and then stored at -20
0
C prior to dye extraction. For quantification of 
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mineralization, alizarin red stain was removed from the scaffold by treating with 500 μL of 
cetylpyridinium chloride for 1 h. Then 200 μL of the extract was taken in a microtiter plate and 
the absorbance was recorded in a microplate spectrophotometer (Biotek PowerWave XS) at 550 
nm. Scaffolds without hMSCs treated following the same protocol were used as control. 
4.4.8.4 RUNX2 expression 
The osteogenic differentiation capacity of MSCs seeded constructs were also assessed by 
evaluating the expression of RUNX2 by immune cytochemistry using fluorescence microscope 
[139]. As per the procedure described above, MSCs seeded scaffolds were incubated. The 
constructs were then fixed and permeabilized with 100% precooled methanol for 10 min. FBS 
were added for non-specific blocking of the reaction. The constructs were treated with primary 
antibody, RUNX2 (1:1500 in PBS) and incubated overnight at 4
0
C. After washing with FBS, the 
samples were treated with FITC conjugated 20 antibody (1:1500 in PBS) and incubated for 1 h.  
The cell samples were then subjected to counter staining with HOEST for 2 min after PBS 
washing and then confocal microscopy images were taken. 
4.4.8.5 Osteocalcin expression  
After 14 days of culture in osteogenic media as described above, the cell-scaffold constructs 
were extracted and fixed using 70% ethanol in 1×PBS for 15 min at room temperature. The fixed 
cells were washed twice in 1×wash buffer (1×PBS containing 0.05% Tween-20). To induce the 
permeability of the cells, 0.1% Triton X-100 in 1×PBS solution was added for 5 min and then 
washed twice with a wash buffer. Afterwards, the samples were incubated for 1 h at room 
temperature in 5% BSA/1× PBS followed by the addition of anti-osteocalcin (anti-OCN) 
antibody (1:1000, Abcam Biotechnology) and incubated overnight at 4
0
C. Following incubation, 
the cells were washed 3 times for 5 min with a 1×wash buffer. Goat anti-rabbit IgG-TRITC 
(1:500, Santa Cruz Biotechnology) and FITC-conjugated phalloidin (1:40, Invitrogen) in 1×PBS 
were added for double staining and cells were then incubated again for 1 h at room temperature 
[16]. The cells were washed with 1×wash buffer for 5 min for three consecutive times. The 
samples were stained by DAPI (1:1000, Chemicon) for nucleus staining and then inverted onto 
cover slips, mounted, visualized and photographed by a fluorescence microscope.  
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4.4.8.6 Osteocalcin activity  
A quantitative estimation of osteocalcin activity was done by enzyme linked immunoassay kit 
(Biomedical Technologies) following manufacturer’s protocol. The assay is a sandwich 
immunoassay employing two monoclonal antibodies directed toward the amino and carboxy 
terminal regions of osteocalcin. Briefly, 25 μl of medium from the cell-scaffold constructs was 
added to the strip plates coated with primary antibodies followed by the addition of 100 μl of 
secondary antibody with incubation for 2.5 h. The samples were then aspirated and washed 
thoroughly with a buffer. 100 μl of streptavidin horse radish peroxidase was added to the plates 
and incubated again for 30 min. Finally 100 μl of substrate was added after washing the plates in 
buffer and allowed to develop color in dark for 10 min. 100 μl of stop solution was added and 
absorbance was read at 450 nm. The amount of osteocalcin was calculated from the absorbance 
using a standard curve.   
4.4.8.7 Morphological study of differentiated MSCs 
The electrospun SF nanofibers were collected on a round glass slip of 15 mm diameter and 
nHAp was deposited on the surface by alternate soaking in CaCl2 and sodium phosphate 
solution. The mineralized fibers were sterilized under UV light for 3 h and washed thrice in PBS 
for 15 min to remove any residual solvent present. Thereafter, fiber coated glass slides were 
immersed in complete medium (DMEM F12 medium/10%FBS 1%antibiotics) overnight before 
cell seeding. The passage 4 MSCs were then seeded on scaffolds with a cell density of 10
4
 
cells/well. After 48 h of cell incubation, the cell scaffold constructs were cultured in osteogenic 
media and after 2 weeks of growth, the cover slips were visualized under inverted microscope to 
observe cell morphology. 
4.4.9 Statistical Analysis 
Statistical significances were determined for all types of scaffold samples for a number of 
triplicates and p values were generated by ANOVA using Benferronies test for multiple 
comparisons to one control (p0.05>3 assay). This assay method relies on assumption of normality 
and homogeneity of variation of distribution. 
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SF derived from silk worm cocoon has been considered as a potential biomaterial for developing 
tissue engineered scaffolds because of its robust mechanical strength, desired biocompatibility 
and suitable biodegradability properties. For application in bone tissue engineering, scaffold 
should possess a desired set of tailored properties like high porosity, high mechanical strength, 
surface hydrophilicity and roughness etc. SF derived from B. mori silk has been widely studied 
by several scientists to develop scaffolds. However, B. mori SF has low hydrophilicity as well as 
roughness that limit its application in bone tissue engineering. Keeping this in view, an attempt 
has been made to explore different silk worm cocoons that are grown locally having superior 
properties compared to the most widely used silk B. mori. Among various types of silk worm 
cocoons, tasar silk has been reported to have better surface properties due to the presence of cell 
binding epitope RGD and high content of hydrophilic amino acids in tasar silk as compared to 
other silks [79]. In addition, tasar silk also possess anti-inflammatory, cytocompatibility and cell 
adhesive properties. Though all these properties make tasar an excellent candidate as scaffold 
material, it is not readily spinnable because of the presence of bulky group of amino acid chains. 
On the other hand, eri silk contains amino acids with positive charge that enhances cell 
attachment in addition to having lowest inflammatory activity among all varieties of silk 
available in India [140]. Moreover, eri silk is highly crystalline than any other non-mulberry silks 
and has excellent blending possibilities with other fibers like wool, cotton and polyester [141]. It 
is thus hypothesized that the combination of the properties of these two varieties of silks may be 
useful to develop a novel biomaterial that can be used for scaffold development for possible bone 
tissue engineering application. So in this part of research work, an effort has been given to 
develop SF blends from eri and tasar silk by finding a suitable solvent system for successful 
spinning of this blend to prepare electrospun nanofiber. 
5.1.1 Selection of solvent for the preparation of spinnable SF blend 
The selection of suitable solvent or solvent system to make a particular polymer spinnable is a 
fundamental requirement [142,143]. It is critical to find a desirable solvent system when a new 
polymer is explored for making electrospun fibers as in the present case of eri and tasar SF. So a 
number of widely used solvents were examined for their suitability to prepare spinnable solution 
of eri and tasar SF and the results are described here. 
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Effect of single solvent system 
Widely used solvents namely formic acid [88], choloroform [126,144,145], trifluro-acetic acid 
[126], hexa-fluro-iso-propanol [87] and water [84] for the preparation of spinnable SF solution 
from conventional B. mori were investigated in this study to make SF solution. The solubility 
and electrospinnability of SF solution in different solvents are tabulated in Table 5.1 and 5.2. The 
concentration of SF solution was 9% w/v for all the cases, selected based on the literature [144]. 
Table 5.1 shows that SFs derived from eri and tasar are soluble in all solvents except chloroform 
in which these are sparingly soluble. However, SF solutions are not spinnable. 
Table 5.1: Solubility and spinnability of eri and tasar SFs in different solvents 
Solvent  Eri silk fibroin Tasar silk fibroin 
Solubility Spinnability Solubility Spinnability 
Chloroform  Sparingly Spray Sparingly Spray 
Formic acid  Fully  Spray Fully Spray  
HFIP (Hexafluro isopropanol)  Fully  Transition-spin  Fully Transition-spin  
TFA (Trifluro acetic acid) Fully  Spray  Fully Spray  
Water  Fully  Spray transition Fully Spray transition 
 
The possible reason for the limitation of spinnability of SF solution is the increase in geometrical 
bulkiness of the amino acid chains. It has been reported that easily fitted amino acid chain can 
crystallize effortlessly facilitating electrospinning while bulky group of amino acid chains fits the 
fiber lattice improperly reducing the fiber forming ability. The ratio of bulky to non-bulky amino 
acid in case of B. mori is 0.18, whereas the values are 0.24 and 0.33 for eri and tasar silk 
respectively [147]. Therefore, an attempt has been made to formulate a binary solvent system to 
make eri and tasar SF spinnable. In this context, several reports have indicated that chloroform 
can improve the electrospinnability of different polymers when used as a co-solvent [148]. In 
another study, Shenoy et al. have reported the effect of solvent suggesting that mixing solvents 
of lower solubility with higher solubility can produce electrospinnable solutions at lower critical 
concentration of polymer by promoting phase separation [149]. It is further reported that binary 
solvent system may be beneficial and appropriate for dissolving a particular solute or polymer 
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blend to allow electrospinnability. Keeping this in view, the binary solvent system using 
chloroform as co-solvent was explored for making SF solution or its blend. 
  
  
Figure 5.1: Electrospinnability of (a) eri and (b) tasar SFs with formic acid as solvent (c) eri 
and (d) tasar SFs with TFA as solvent 
Among other solvents, fiber produced from B. mori SF using HFIP was reported to be highly 
brittle due to its high volatility and also very expensive. On the other hand, SF is highly soluble 
in water and is very difficult to make spinnable at low concentration. Furthermore, though fiber 
is formed at very high concentration (>30% w/v), the fiber diameter obtained is in micrometer 
range rather than nanometer that is most desirable for tissue engineering. The unsuitability of 
TFA as a solvent for eri and tasar SFs is revealed from SEM images as shown in Figure 5.1 (c) 
and (d). No fiber formation is observed with tasar using both TFA and formic acid. Further, 
fiber-like morphology is found in case of eri silk using formic acid whereas TFA fails. Based on 
(a) (b) 
(d) (c) 
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the above fact, formic acid was chosen as a possible solvent to make a binary solvent system 
with chloroform. 
Effect of binary solvent system 
As it is justified above, formic acid and chloroform in combination were chosen as a possible 
binary solvent to develop spinnable solution from eri and tasar SFs. Different batches of binary 
solvent systems was prepared in varying ratios of formic acid and chloroform. The prepared 
solvent mixtures were evaluated for their suitability for making SF solution spinnable by testing 
in the electrospinning machine and the optimum ratio of solvents mixture was established. The 
experimental results are shown in Table 5.2.  
Table 5.2: Spinnability of eri and tasar SFs in different ratios of formic acid and chloroform 
Formic acid % v/v Chloroform % v/v Spinnability of eri Spinnability of tasar 
90 10  No Fig (b) No Fig (a) 
80 20 No Fig (g) No Fig (d) 
70 30 Spinnable Fig (i) No Fig (e) 
60 40 Spinnable Fig (j) No Fig (f) 
50 50 No Fig (c) No Fig (h) 
 
It is noticed that not a single binary solvent system is able to make electrospun fibers from tasar. 
Furthermore, among the solvent systems used under study, the one prepared with 70:30 and 
60:40 formic acid:choloroform ratios were found to be effective for fiber formation from eri SF. 
This is further evident from SEM images as depicted in Figure 5.2. 
  
(a) (b) 
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(d) (c) 
(e) (f) 
(g) (h) 
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Figure 5.2: SEM images showing spinnability of eri and tasar SFs in different ratios of formic 
acid and chloroform (a) no spinnability of tasar (b) no spinnability of eri (c) no spinnability of 
eri (d) no spinnability of tasar (e) no spinnability of tasar (f) no spinnability of tasar (e) no 
spinnability of eri (f) no spinnability of tasar (g) no spinnability of eri (h) no spinnability of 
tasar (i) spinnability of eri (j) spinnability of eri 
5.1.2 Selection of optimum SF blend composition  
As it is seen in previous section that SF derived from tasar is not spinnable. However, it is 
evident from literature that it is an attractive biopolymer with superior cell supportive properties 
than other type of SF including eri. Therefore, an attempt has been made to make SF derived 
from tasar electrospinnable by blending with spinnable eri SF using the selected solvent 
composition. Different batches of SF blends with varying compositions were prepared and the 
blends were subjected to electrospinning to produce SF fibers. The electrospinning result is 
shown in Table 5.3 and SEM images in Figure 5.3. 
Table 5.3: Effect of SF blend composition and solvent ratio on fiber formation 
Formic acid:  
chloroform 
eri:tasar 
90:10 80:20 70:30 60:40 
70:30 Irregular fiber 
Figure (c) 
Beaded fiber 
Figure (b) 
Beaded fiber 
Figure (e) 
No fiber figure (f) 
60:40 Fiber Figure (g) Fiber figure (h) Fiber Figure (d) Micron sized powder 
figure (a) 
(i) (j) 
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From Table 5.3 and SEM images (Figure 5.3), it was observed that both solvent ratio and blend 
ratio have great influence on fiber formation. Fiber formation was found to be more favorable 
using 60:40 solvent ratio than with 70:30 irrespective of the polymer blend composition. In case 
of latter, fiber formation was observed to be either irregular or beaded which may be attributed to 
the increase in concentration of chloroform that decreases the dielectric constant and increases 
volatility of the solvent mixture [150,151]. Thus it is demonstrated that 60:40 is the optimal 
formic acid:chloroform solvent ratio.  
Furthermore, so far as SF blend composition is concerned, fiber was found to be formed with all 
SF blend ratios except SF blend with 60:40 ratio of eri:tasar. The progressively better fiber 
formation in terms of fiber diameter as measured from SEM images was achieved with blend 
containing higher content of SF derived from eri. Comparable though slightly higher fiber 
diameter was obtained using SF blend with higher amount of tasar up to 30%. Keeping in view 
of utilizing the maximum amount of tasar as desirable, blend with 70:30 eri:tasar was selected as 
the optimum SF blend for further studies. 
  
  
(a) (b) 
(c) (e) 
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Figure 5.3: SEM images of different SF blend composition at solvent ratios of formic acid and 
chloroform (70:30 and 60:40) (a) Micron sized powder (b) beaded fiber (c) irregular fiber (d) 
fiber (e) beaded fiber (f) no fiber (g) fiber (h) fiber 
5.1.3 Effect of SF blend concentration on fiber formation 
Previous study has suggested that polymer solution concentration is one of the most influential 
factors that significantly affect electrospinnability of solution and morphology of electrospun 
nanofiber. It has been reported that the value of critical minimum concentration is dependent on 
the molecular chain length, chemical nature of polymer and type of solvent system for a selected 
polymer [152,153]. Therefore, the effect of polymer solution in varying concentration in the 
range 6-9% w/v was investigated on the spinnability and morphology of fiber formation from SF 
blend to obtain the optimal concentration. The electrospinning condition is performed with an 
applied voltage varying between 18 kV, tip-collector distance 15 cm and flow rate 0.8 ml/hr 
(e) (f) 
(g) (h) 
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throughout the experiment. The first two parameters were adjusted to maintain a continuous fiber 
formation. The experimental result is shown Figure 5.4.  
  
  
Figure 5.4: Effect of SF concentration on nanofiber formation (a) 9% (b) 8% (c) 7% (d) 6% 
SF blend concentration 
It is observed from SEM images that fiber formation is highly dependent on the concentration of 
polymer blend. The minimum blend concentration for fiber formation is 8% w/v below which no 
fiber is formed. Furthermore, though clear fiber formation was obtained using higher 
concentration of blend (9%), 8% is considered as the most favorable for producing less fiber 
diameter which is desirable for tissue engineering scaffold development. 
 
 
(b) (a) 
(d) (c) 
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5.1.4 Properties of SF blend solution 
Specific viscosity and surface tension 
Viscosity and surface tension have strong influence on fiber formation from polymer. The 
viscosity of a polymer solution is directly proportional to fiber diameter whereas surface tension 
helps in the formation of stable pendant droplet (formation of Taylor cone at the needle tip) 
thereby, facilitating fiber formation. From Table 5.4 it has been observed that with the decrease 
in SF concentration, specific viscosity of the solution decreases while surface tension does not 
vary significantly. Hence, a direct relationship between the concentration of blend solution and 
specific viscosity has been suggested.  
Table 5.4: Effect of total concentration of SF blend on viscosity of solution 
Concentration Silk 
composition 
(eri:tasar) 
Solvent 
composition\ 
(FA:Chloroform) 
Specific 
viscosity 
Surface tension 
(mN/m) 
9% 70:30 60:40 70.5 26.85 
8% 70:30 60:40 64.8 26.02 
7% 70:30 60:40 53.1 25.67 
6% 70:30 60:40 48.6 25.32 
 
Stability of SF blend solution 
Storage time has a great influence on the shear viscosity that ultimately affects the spinnability of 
a polymer solution. Therefore, it is important to check the stability of SF blend solution over 
time. Figure 5.5 represents the change in shear viscosity of SF blend as a function of time. After 
a slight decrease in shear viscosity (within 1
st
 few hours) at the initial stage, viscosity increased 
up to 2-3 h and thereafter, a decline in trend in shear viscosity was observed. This phenomenon 
may be explained as during the initial phase some transition in form might have occurred which 
is followed by the formation of aggregate resulting in an increase in viscosity; the decrease in 
viscosity is probably due to decomposition of polymer. As it is seen from Figure 5.5, SF blend 
solution is stable up to 4 days with desired spinnability characteristics. 
Results and Discussion 
 
53 
 
 
Figure 5.5 Change in shear viscosity of SF blend as a function of time 
5.1.5 Conclusion 
The main aim of the present work was to develop a spinnable SF blend solution from eri and 
tasar silk by selecting a suitable solvent system. Spinnable SF blend was prepared successfully 
by selecting a binary solvent mixture consisting of 60:40 v/v formic acid and chloroform. 8% 
w/v is established as the optimum concentration of SF blend solution for nanofiber formation. 
Furthermore, the stability of the SF blend solution was found to be 96 h for nanofiber formation. 
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As it has already been mentioned that the design and fabrication of a 3D scaffold from suitable 
biocompatible and biodegradable polymeric materials is one of the key challenges in bone tissue 
engineering. In scaffold designing, architecture and molecular composition are reported to be 
most critical. It is important to understand whether the developed scaffold serves as a mere 
passive substrate or rather actively affects cellular and synthetic processes involved in ECM 
formation. Biomaterials derived from natural biopolymers e.g. SF are potential candidates to 
meet the requirement of the latter because of their intrinsic bioactive properties whereas the 
development of a 3D nanostructured scaffold is an essential feature that can regulate vital 
cellular functions such as adhesion, proliferation, migration and differentiation.  
Keeping above issues in view, in previous chapter, a novel scaffold material was developed from 
SF blend derived from eri and tasar silk and further non-woven electrospun nanofibers were 
made from the blend successfully by electrospinning. In this phase of thesis work, research has 
been further extended to fabricate 3D nanostructure from the developed nanofibers by 
electrospinning. These scaffolds were further characterized for surface, mechanical and 
biological properties. The results and discussion are described in this chapter.  
5.2.1 Fabrication of electrospun 3D nanofibrous SF blend mat 
To achieve continuous nanofiber deposition on the collector, the three important electrospinning 
parameters voltage, tip-collector distance and flow rate were adjusted to compensate the decrease 
in conductivity of collector plate as observed during electrospinning. The corresponding range of 
these parameters were varied with applied voltage between 18-22 kV, flow rate 0.5-0.8 ml/h and 
tip collector distance 15-12 cm. The entire process was carried out at 65% relative humidity at 
room temperature. Finally, a 3D mat of thickness 300±10 µm was prepared by layer-by-layer 
deposition of SF nanofibers generated by electrospinning. It was observed that the electric field 
varied within 1.2-1.8 kV/cm range during the entire process.  
5.2.2 Characterization of scaffold 
The prepared 3D nanofibrous scaffolds were characterized for morphological, mechanical, 
structural, thermal and biological characterization to find its suitability in bone tissue engineering 
application. 
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5.2.2.1 Morphological studies  
The morphology of the prepared nanofibrous mat was characterized by SEM, AFM and TEM. 
The results are described below. 
SEM Analysis 
SEM images (Figure 5.6 a) revealed that SF fibers are randomly aligned which is attributed to 
continuous deposition of nanofiber. Further, on close observation (Figure 5.6 b), it is shown that 
these randomly oriented nanofibers (in the selected area of analysis) lead to interconnected voids 
resulting in porous structure of the scaffold. The fiber diameter was found in 200-500 nm range, 
average being 350 nm. They were observed to be more or less uniform throughout its entire 
length while the deposition is non-uniform in nature which is possibly due to the change in 
conductivity of the collector with increase in surface deposition [154]. 
  
Figure 5.6: SEM images of eri-tasar SF blend nanofibrous mat. Images taken at 2500 and 
15,000 magnification. Images show randomly oriented nanofibers with interconnected voids. 
(a) (b) 
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Figure 5.7: Distribution of electrospun fibers diameter with random orientation 
The statistical distribution of fiber diameter was also analyzed by NIH Image J software by 
taking SEM images at high magnifications >2500X and 5000X. 20 different Figures have been 
taken for the analysis for an approximate ~500 measurements that were recorded to plot the 
graph (Figure 5.7). The fiber diameters thus measured were found within the range 200-750 nm 
with majority of fibers in 200-500 nm range. The variability in fiber diameter is similar to the 
variation in fiber diameter of natural ECM and thereby, speculates to mimic the natural 
microenvironment by providing large number of binding sites for cell attachment as reported 
earlier [155]. 
AFM analysis 
Surface roughness is an important property for cellular adhesion and immuno compatibility of 
scaffold. The surface roughness of the prepared scaffolds was measured by AFM as shown in 
Figure 5.8 (a-e). The average roughness of 3D nanofibrous scaffold was found to be in the range 
0.387-0.4387 µm which is highly favorable for cytocompatibility and protein adsorption for 
successful tissue regeneration [156,157]. 
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(a) 
Ra =0.387µm 
(b) 
(a) 
Ra =0.4203µm 
(c) 
Ra =0.4224µm 
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Figure 5.8: Average roughness of SF blend mat as expressed at 5 different positions TEM 
analysis  
The shape and smoothness of nanofibers are further observed from TEM images. As observed in 
Figure 5.9, individual fibers were found to be flat and smooth. 
(d) 
Ra =0.4378µm 
(e) 
Ra =0.4183µm 
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Figure 5.9: TEM images of a single nanofiber representing its shape and surface view. 
5.2.2.2 Porosity and pore size distribution 
Figure 5.10 shows the relationship between differential intrusion volume and pore size. Majority 
of pore sizes of the 3D mat (scaffold) was measured to be within 2500-5000 nm range and the 
ratio of pore diameter to fiber diameter was 3:4. 
 
Figure 5.10: Plot of differential intrusion volume vs. pore diameter of electrospun SF blend 
nanofiber 
(a) (b) 
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The average porosity of the scaffold was measured as 79±5%. This porosity range is favorable 
for effective transfer of nutrients, oxygen and disposal of metabolic byproducts essential for 
survivability of any tissue engineered construct [158]. Pore shape plays a significant role in 
cellular proliferation and especially on differentiation of MSCs [159]. 
The volume of intrusion was observed to be less than that of measured volume as evident from 
Figure 5.11. This may be due to trapping of some mercury at depressurization step within void 
space that was unable to extruded [124]. This incomplete removal of mercury causes hysteresis 
loss for electrospun nanofibrous mat. This is supposed to be a result of existence of ink-bottle 
type of pores with a small throat to cavity ratio. It is to be noted that in case of cylindrical pores 
the hysteresis loss is minimum ~0. The adhesion, growths and proliferation of cells over scaffold 
require proper exchange of nutrients, growth factors, gases (O2 and CO2) and waste products. 
Presence of ink bottle type of pores speculates that the above transport will follow non-Higuchi's 
equation i.e. release is regulated by physical and elastic property of nanofiber in addition to 
diffusion [160]. 
 
Figure 5.11: Plot of measured and corrected intruded volume vs. pressure for electrospun 
samples with fiber diameters 0.3-0.6 μm  
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5.2.2.3 Structural analysis 
XRD diffractogram (Figure 5.12) shows the diffraction pattern for SF blend nanofibrous scaffold 
at 20.55 (2θ) and corresponding space d=4.387 Å for α-helix structure and it is diffraction for β-
structure 29.54 (2θ) and space = 3.123 Å [93,159] indicating the presence of α and β structure in 
the nanofibrous mat. 
 
Figure 5.12: XRD analysis of SF blend nanofibers 
FT-IR spectrum was carried out for eri-tasar SF scaffold to confirm the presence of functional 
groups in the SF blend scaffold. From Figure 5.13, it was observed that the C=O stretch vibration 
of amide I band absorbed at 1658 cm
-1
 and  N-H bending of amide II band absorbed at 1530 cm
-1
 
for both SF blends as observed from the presence of two prominent peaks [94]. 
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Figure 5.13: FT-IR analysis of SF blend nanofibers showing functional groups of SF 
5.2.2.4 Thermal analysis 
From Figure 5.14 of TGA, the weight loss occurred about 7-8% at 100
0
C due to water 
evaporation from SF blend scaffold which is insignificant. The blended SF scaffold started to 
decompose around 250-300
0
C and its residual weight loss was about 20%. Further increase in 
temperature of the scaffold produced severe decomposition at 350
0
C and weight loss around 45-
50% due to the peptide bond breaking into amino acid as reported earlier [162]. 
 
Figure 5.14: TGA of eri-tasar SF nanofibrous scaffold 
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5.2.2.5 Mechanical properties 
The tissue engineered scaffold must have high tensile strength which is an essential factor to 
withstand in vitro cell growth and neo tissue organization. Moreover, scaffold must have desired 
elastic modulus to facilitate osteogenic differentiation of cells. Therefore, the tensile strength and 
% elongation of the prepared scaffold were measured by a mechanical tester. Figure 5.15 (a-b) 
shows a load-extension graph of eri-tasar and BM silk fibroin nanofibrous scaffolds indicating 
ultimate tensile strength at maximum load. It is observed that SF blend (ET) nanofibrous scaffold 
show a higher UTS (1.83 Mpa) and percentage of extension (7.256%) as compared to widely 
used scaffold derived from BM (UTS 1.378) and (5.917%). The higher UTS and % extension 
represent higher ductile nature of SF blend scaffold as compared to BM scaffold. The  
mechanical properties of cancellous bone tissue is a function of anatomic location and the wide 
range of  tensile strength values have been reported by different researchers, for example,  
proximal tibia (0.2 to 6.7 MPa [163], proximal femure (0.2 to 14.82 MPa) [164] and vertebral 
bodies (0.3-7 MPa) [163]. Thus it has been demonstrated that the developed nanofibrous scaffold 
posses desired mechanical property suitable for various non-load bearing bone tissue engineering 
application. Furthermore, the ET scaffold is superior in mechanical property than the most 
widely used Bombyx mori scaffold. 
 
 
(a) 
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Figure 5.15: Typical load vs. extension curve of (a) SF blend (eri-tasar) and (b) B. mori 
nanofibrous scaffold. 
5.2.2.6 Water uptake capacity and contact angle measurement 
The hydrophilic of scaffolds is determined by swelling property and contact angle measurement. 
The measured properties were also compared with B. mori nanofibrous scaffold. Figure 5.16 
shows the swelling index of SF blend and B. mori scaffold for a 96 h to determine the 
equilibrium swelling ratio and onset of material degradation. Figure 5.16 indicates that there is a 
gradual increase in water uptake capacity of the scaffold with time and maximum at about 30 h. 
Afterwards there is no further change in water uptake representing the attainment of equilibrium. 
The maximum % water uptake and corresponding swelling ratio of SF blend is 43% and 0.73 
respectively. The values are also found to be higher than the water uptake (37%) and swelling 
ratio (0.64) observed with B. mori scaffold that represent superior surface property 
(hydrophilicity) of SF blend (eri-tasar) scaffold than the widely used B. mori scaffold. 
Furthermore, the water uptake capacity and corresponding swelling ratios measured based on 
distilled water and PBS are nearly same. 
(b) 
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Figure 5.16: Water uptake capacity of SF blend and BM scaffolds for 96 h of treatment in 
SBF 
The high hydrophilic property of SF blend can be explained owing to the presence of higher 
hydrophilic amino acid [80] content compared to B. mori scaffold. Higher hydrophilicity of SF 
blend scaffold facilitates better transport of nutrients, growth factors and gas exchange that 
favors cell attachment and immunocompatibity [165]. The nanofibrous mats were further found 
to be visibly fragmented after 96 h of treatment and hence further experiment was not 
appropriate for data analysis. However, the measured contact angle of SF blend (eri-tasar) and B. 
mori nanofibrous mat in water were found to be 54.7±1.80 and 62±2.30 respectively. This 
further supports the high hydrophilicity of SF blend nanofibrous mat and thereby, its superior 
surface property.  
5.2.2.7 Bioactivity of the scaffold 
Bioactivity of 3D nanofibrous scaffold to form bone like apatite reflects its bone binding 
potential [166,167]. This property improves healing through accelerated regeneration of bone 
tissue and deposition of HA. Therefore, the bioactive potential of the developed scaffold was 
assessed by SEM and EDX analysis. It was observed from Figure 5.17 that the white color 
globular particles deposited on the surface were apparently similar to apatite. This was confirmed 
by EDX analysis that revealed the ratio of Ca:P as 1.64 and 1.57 for (a) eri-tasar and (b) B. mori 
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nanofibrous mat respectively [168]. The result is in good agreement with the reported value of 
the  ratio of Ca : P in human bone which varies between 1.5-1.7 [169].  
  
  
Figure 5.17: SEM images shows deposition of HAp over (a) SF blend and (b) B. mori 
scaffolds and corresponding EDX figures after soaking in SBF for 14 days 
Furthermore, on close observation of images, it was demonstrated that the particles are 0.5-3 μm 
diameter. The formation of HAp further depicts the growth of HAp crystals over eri-tasar and B. 
mori are comparable. Thus it proves that the scaffold has possessed desired bioactive properties 
suitable for bone tissue regeneration. 
5.2.3 Mechanism of biodegradation 
The self-repairing ability of various tissues such as bone, tendon, ligament and vessel are 
different implying that scaffold should have corresponding degradation rates to facilitate new 
tissue synthesis. Hence, the degradation control of different scaffold is still the major goal of 
tissue engineering research. The degradation is a serious issue for silk based material application 
(a) 
(b) 
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in tissue engineering [170]. It is utmost important that the substitute artificial ECM should retain 
adequate mechanical strength during these period for tissue regeneration in spite of degradation. 
Additionally, the physicochemical property should not change drastically so that the requirement 
for complete tissue healing is hindered [171]. Furthermore, literature study suggests that β sheet 
content play a critical role in degradation of SF nanofibers. During the fabrication processes, silk 
I which is more amorphous in nature having α sheet configuration transformed into silk II i.e. β 
sheet configuration possessing more crystallinity. In this present study, the degradation 
mechanism of SF nanofibrous mat obtained through electrospinning has been established for 
understanding the correlation between structure, processing and degradability. The study of 
degradation mechanism would produce a more controlled degradability of SF nanofibrous 
structure. This will result in regeneration of various tissue structures as per requirement. 
5.2.3.1 Biodegradation of silk nanofibrous scaffold 
The weight loss due to protease XIV treatment of nanofibrous scaffold at 37
0
C and 24 h is shown 
in Figure 5.18. The figure shows the percentage of degradation increases with time. After 24 h, 
24% and 27% weight loss were observed in treated B. mori and eri-tasar nanofibrous mat 
respectively. In contrast, very little weight loss is observed for these nanofibrous mat after 2 
weeks in PBS without enzyme. The increased weight loss percentage with eri-tasar scaffold is 
due to the high content of hydrophilic amino acid with bulky side chain which facilitates water 
permeation and creates imperfection during fiber formation [172].  
 
Figure 5.18: Percentage degradation of blended SF blend and B. mori scaffolds in Protease K 
in SBF (n=5). 
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Since the eri and tasar silks are different in composition of amino acid and its repeating pattern, a 
little increase in rate of degradation (3%) has been observed after 24 h of treatment. Further 
analytical study has been performed to find out the degradation mechanism of eri-tasar 
nanofibrous sheet.  
5.2.3.2 Tensile strength of SF blend nanofibrous mat due to enzyme treatment 
The effect of biodegradation by enzyme treatment on tensile strength of scaffold was 
investigated as shown in Figure 5.19. The result indicates that the enzymatic degradation has an 
adverse effect on the tensile strength of both eri-tasar and B. mori scaffolds. Further, the loss of 
tensile strength for ET is higher than the loss observed with B. mori nanofibrous scaffold. 
 
Figure 5.19: Tensile strength of nanofibrous SF blend scaffolds and B. mori before and after 
enzyme treatment for 12 h  
5.2.3.3 Structural changes in SF nanofibrous scaffold upon enzyme treatment 
FT-IR  
It is important to examine whether degradation has any influence on the conformational changes 
of scaffolds. FT-IR analysis was performed with 32 scans with a resolution of 4 cm
-1
, with wave 
number scanning range from 1200-1800 cm
-1
. This study has been carried out for identification 
of functional groups and their conformations. SF consists of 2 types of crystalline structure silk I 
and silk II [173]. Figure 5.20 (a) represents the IR spectra of SF nanofiber while (b) and (c) 
represent its enzymatically degraded product after 12 and 24 h respectively implying certain 
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structural changes. The spectral regions 1700-1500 cm
-1 
are owing to the absorption by peptide 
backbone and hence used for the analysis of secondary structure with amide I 1700-1600 cm
-1
 
and amide II 1600-1500 cm
-1
. The peaks 1610-1630, 1695-1703 and 1510-1525 cm
-1
 are 
characteristics of silk II secondary structure and 1648-1654 and 1535-1542 cm
-1
 for silk I 
conformation [174]. 
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Figure 5.20: FT-IR analysis of degraded SF blend nanofibrous mat that was cultivated in 
protease XIV solution for (a) 0 (b) 12 and (c) 24 h  
It was observed three strong peaks at 1685, 1675 and 1523 cm
-1
 for SF nanofibrous mat in Figure 
5.15 (a). The peak 1523 cm
-1
 corresponds to silk II secondary structure while peaks 1685 and 
1675 cm
-1
 show the presence of helical turns in SF chain inside the nanofiber [175]. In Figure 
5.20 (b), two strong peaks are observed at 1629 and 1697 cm
-1
 corresponding to β-sheet 
conformation of nanofiber while another weak low intense peak at 1542 cm
-1
 corresponds to silk 
I conformation. This demonstrates high rate of silk I degradation and low rate of silk II 
degradation initially. In Figure 5.20 (c), it is observed three peaks (after 24 h of treatment) such 
as 1670, 1605 and 1510 cm
-1
. The peak at 1605 cm
-1
 (Figure 5.15) corresponds to accumulation 
of fragments with high tyrosine content and other bulky amino acids and 1670 cm
-1
 indicating 
small turns in degraded fragments [176]. The peak at 1510 cm
-1
 corresponds to the presence of 
silk II secondary structure. This depicts the initial degradation of non-crystalline silk I and 
amorphous portions of SF nanofiber. The silk II crystalline fragments are observed even after 24 
h of enzymatic degradation, however their intensity is less. Similar finding have been reported by 
Kaplan et.al in silk film of B. mori [125].  
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From the study, it can be observed that during the initial period, β crystalline fragments are 
separated due to enzymatic degradation of amorphous content. Accumulation of fragments 
containing bulky side chain occurs after initial period of digestion. The solubility of crystalline 
fragments occur which may decrease the rate of degradation of crystalline content after fragment 
separation. 
XRD 
XRD was performed to further assess any conformational or phase change occurred in SF 
scaffolds during enzyme degradation. XRD (Figure 5.21) indicates the change in degree of 
crystallinity and also the change of α and β fragments after enzymatic action for certain time 
period i.e. 0, 12 and 24 h. Figure 5.21 shows a prominent peak at 20.55
0
, d = 4.387 Å which 
corresponds to α helix that gets reduced after 12 h of treatment. A prominent peak at 2θ = 29.540, 
d = 3.123 Å is observed after 12 h of study which is also present in the rudimentary form. 
 
Figure 5.21: XRD analysis of degraded SF blend nanofibrous mat that was cultivated in 
protease XIV solution for (a) 0 (b) 12 and (c) 24 h. 
This indicates increase in β sheet content after 12 h because of the digestion of α fragments and 
amorphous materials. The crystallinity of nanofibrous structure increases because of the 
dissolution of amorphous content of polymer, thus increasing the percentage of crystallinity. It is 
possible that this dissolution of amorphous content provide energy for recrystallization of certain 
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fragments. The 3
rd
 curve (blue curve) in Figure 5.21 (c) indicates the decrease in crystalline and 
amorphous fragments at the same rate and no peaks are observed after 24 h of treatment except a 
broad hump demonstrating irregular crystalline fragments of SF nanofibers. The above 
phenomenon further supports that initial enzymatic degradation occur at α coils and amorphous 
structure.  
DSC 
DSC was performed to understand the interaction between bound water and hydrophilic amino 
acid present in the SF nanofibers. The endothermic peak of Figure 5.22 indicates Tg (1) (lower 
glass transition temperature) of SF nanofiber and its degraded product are within 50-70
0
C range.  
 
Figure 5.22: DSC analysis of degraded SF blend (eri-tasar) nanofibrous mat cultivated in 
protease XIV solution for (a) 0 (b) 12 and (c) 24 h  
This demonstrated the presence of bound water and its interaction with hydrophilic amino acid in 
SF nanofiber and its degraded products [177]. This prompted its further analysis about the 
mechanism of degradation and factors affecting it. 
TM-DSC 
The glass transition temperature of nanofibrous mat after 0, 12 and 24 h of degradation are 
shown in Figure 5.23. 
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Figure 5.23: TM-DSC plot of degraded SF blend (eri-tasar) scaffold that was cultivated in 
protease XIV solution for (a) 0 (b) 12, and (c) 24 h 
It shows that Tg (1) for nanofibrous mat and its degraded mat after 12 and 24 h are found to be 
68.5
0
C, 56
0
C and 45
0
C respectively. SF nanofiber can be considered as semicrystalline system of 
SF protein and water. Tg of such a protein-water system in presence of small amount of non-
freezing bound water and protein with high amino acid content is markedly affected because of 
the breaking of intermolecular H bonding [178]. Thus a decrease in Tg value with respect to 
progress of enzymatic degradation reaction is noticed after 12 and 24 h. This further supports the 
presence of high hydrophilic amino acid content in nanofibers. In contrast, the sample whose 
major constituents are hydrophobic amino acid groups, Tg maintains a constant value regardless 
of water content due to lack of intermolecular H-bonding. The stabilization of hydrophobic 
groups by higher order structures is found in β sheet conformation [179]. This study suggests 
that hydrolysis of SF nanofiber continued throughout 24 h. 
TM-DSC (Cp) 
Figure 5.24 shows specific heat capacity (Cp) for SF nanofiber at Tg (1) for the sample treated 
with enzyme for 0, 12 and 24 h. The nanofibrous mat shows highest Cp value as compared to the 
rest two degraded products as expected. In contrast, the observed Cp value for sample treated 
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with enzyme for 12 h are lower than that of sample treated for 24 h. This ambiguity of Cp 
variation shows the influence of some other parameters in this degradation processes.  
 
 
Figure 5.24: TM-DSC plot of degraded SF blend (eri-tasar) scaffold that was cultivated in 
protease XIV solution for (a) 0 (b) 12 and (c) 24 h. 
The reduction in heat capacity of SF-bound water system is a result of hydration reaction 
progress which eliminates the hydrophilic amino acid content from nanofibrous sheet and its 
enzymatically degraded products [180]. The resulting fragments produced have high content of 
hydrophobic amino acid with low mobility owing to heavy hydration. The heat capacities of 
bound water indirectly affect the molecular mobility of polymeric chain in water under the 
effect of force field of fragments and dissolved solute particles. The decrease in molecular 
mobility of fragment in water is accompanied by a decrease in heat capacity of bound water 
[181] establishing a linear relationship between Cp and bound water [182] which explains the 
decrease in Cp value upon nanofibrous scaffold degradation. In contrary, a rise in heat capacity 
of SF fragment-water system is observed after 24 h of enzymatic degradation, though a fall in 
Tg is noticed. The reason may be because of interaction of tightly bound water to enzymatically 
degraded SF fragment causing decline in entropy of SF water system. But intermolecular 
conformational changes influence the mechanism of interaction of water molecules with silk 
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fibroin. Thus an unfavorable interaction with hydrophobic fragments and bound water cause 
denaturation of SF fragment due to destruction of ordered water cluster associated with the SF 
molecule inside the nanofiber which increases the heat capacity of fragments after 24 h [183]. 
5.2.3.4 Morphological study   
Figure 5.25 shows the scanning electron micrograph of degraded nanofibrous scaffold after (a) 0 
h (b) 6 h (c) 12 h (d,e) 24 h (f) 48 h respectively to see the change of morphology because of 
degradation. After 6 h of degradation, the core layer swollen globules with 200-800 nm in 
diameter which is still connected with undigested SF fragment (probably β sheet) in Figure 5.25 
(b) are observed. The Figure 5.25 (c) demonstrates the deposition of heavy amount of salt and 
proteins in the degraded structure after 12 h. Thereafter, the α coil structure swells and degrades 
to form globular structures with radiating nanofilaments in Figure 5.25 (d) and (e) while β 
structures are immune to enzymatic degradation and visualized as radiating nanofilaments. After 
48 h of enzyme treatment, irregular, swollen amorphous matrix is visible in Figure 5.25 (f).  
  
 (a) (b) 
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Figure 5.25: Surface and cross-sectional images of SF blend nanofiber mats after enzymatic 
treatment in SBF for (a) 0 h (b) 6 h (c) 12 h (d) and (e) 24 h and (f) 48 h. 
Further surface morphology of nanofibrous mat were analyzed through atomic force microscope 
which are shown in Figure 5.26. Figure 5.26 (a) and (b) correspond to nanofibrous structure 
while (c) after 12 h of treatment shows deposited and fragmented particles over the scaffold 
surface. After 24 h of enzyme treatment, core nanofilaments were observed as seen in Figure 
5.25 (d). Based on the above facts, it can be concluded the following facts. After 12 h of 
degradation, the nanofibrous structures are degraded with swelling and numerous globular 
agglomerated core structures of silk fibroin is visible. The nanofilaments are further observed 
with surrounded interconnecting nanofibrils after 24 h. The degraded particle agglomerate and 
(c) (d) 
(f) (e) 
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nanofilaments of fibers are observed through AFM. Similar observation is noticed by Kim et al. 
in his study [184].  
 
Figure 5.26: AFM images of degraded SF blend nanofibrous mat treated in protease XIV 
solution for (a) and (b) after 0 h (c) after 12 h and (d) after 24 h respectively. 
5.2.3.5 Elucidation of mechanism  
The degradation of high amount of non-crystal hydrophilic blocks make free the tiny 
hydrophobic crystal blocks which moves away without being degraded. Similar predictions are 
done in silk film biodegradation study by Kaplan et al [125] . However, the degradation may be 
more favorable than the SF of B. mori because of the presence of hydrophilic amino acid 
containing bulky side group providing more defects in semi-crystalline fibers. Thus the decrease 
in crystallinity of fiber is either by dissolution or migrations of hydrophobic nanostructure rather 
than degradation as these structures are immune to enzymes comparatively. Moreover, the high 
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porosity and surface area of the nanofibrous scaffold provides higher rate of enzyme action 
demonstrating faster degradation kinetics.  
Our result supports the previous report that hydrophilicity accelerates SF fragmentation and 
biodegradation [185]. The non-crystal and silk I structure degrade more quickly to separate the 
silk II content after 12 h of protease treatment in solution. Thus the increase in β content/silk II 
conformation increases the resistance to degradation by enzyme. Thereafter, further degradation 
of silk I present along with β structure is accelerated because of the enhanced surface area of 
fragments which allows penetration of water molecules containing enzyme causing chain 
separation. The entry of water molecules into the fragments of SF nanofibers creates ion-dipole 
interaction with negative charge of SF protein and thereby decreases inter/intra molecular 
friction between the chains and increase their mobility and separation. This has been attributed 
by decrease in crystallinity of nanofibrous structure as observed in Figure 5.26 (c). This 
fragmentation process further shortens the silk II crystal fragments which are removed either by 
solubilization or by migration from the site through solvent flow. Thus a fall in concentration of 
silk I and silk II occurs simultaneously after 12 h resulting in decrease in both silk I and silk II 
content after 24 h. The solution after 24 h of degradation has been filled with nanofilaments and 
particles with 10-100 nm in diameters (Figure 5.26 (d)).  
Our study is silent regarding the role of continuity, polydispersity of fibers and presence of 
bending in coils which are important factors in determining the action of enzymes on SF 
nanofibrous sheet. Nevertheless, these factors hold minimum significance in elucidating basic 
mechanism of SF blend nanofibrous degradation processes because of its major dependence on 
hydrophilicity, β sheet structure and crystal-non crystal content. The efficiency of proteosomal 
degradation in eri-tasar blend is expected to decrease after 12 h because of substrate unfolding 
caused by alternate repeat of glycine and alanine [186]. This has been supported by our study 
which showed 18-19% degradation during initial 12 h of enzyme treatment, followed by 7-8 % 
of degradation in next 12 h (Figure 5.26 (c and d)). On the other hand, high Asparagin content 
along with higher amount of Asp-Gly dipeptide sequence in eri-tasar blend is likely to promote 
faster hydrolysis and deamidation reaction initially to form cyclic imide intermediate with the 
cleavage of peptide chain accelerating biodegradation [187]. The above mechanism requires 
further study to determine the detailed molecular mechanism to modulate degradation behavior. 
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Additionally, the faster degradation of scaffold induces formation of higher osteogenic extra 
cellular matrix as suggested by Park et al [188].  
5.2.4 In vitro cell culture study 
5.2.4.1. Characterization of hMSCs 
Cultured hMSCs up to 4
th
 passage was used for cell culture study to examine the cell supportive 
property of the developed scaffold. The morphological characterization of hMSCs was done by 
phase contrast microscopy, the images of which are shown in Figure 5.27. The cells are found to 
be MSCs as evident from their fibroblast-like cell morphology.  
  
  
a b 
c d 
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Figure 5.27: Morphological observation of hMSCs under phase contrast microscope at 
magnification 5X (a) day 1 (b) day 2 (c) day 3 (d) day 5 (e) day 7 (f) day 14 of 4
th
 passage 
Further, the immunophenotypic characterization of hMSCs was studied by flow cytometry 
analysis. The immunophenotypic characterizations are shown to be positive for CD90 (99.01%), 
CD73 (95.5%) and CD105 (96.5%) expression and negative for CD34 (1.0%), CD45 (0.5%), and 
HLA-DR (1.2%) indicating the cells are MSCs. Immnuoﬂuorescence also found to express 
CD90, and CD105, but not the hematopoietic origin marker CD34 as shown in Figure 5.28. 
CD90-APC     CD105-PE 
 
CD34-PE     CD45-PerCP 
 
e f 
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HLA-DR-PerCP    CD73-APC 
 
Figure 5.28: Flow cytometric analysis for the expression of MSCs markers CD90, CD105, 
CD73 (+ve markers) and hematopoietic CD34, HLA-DR and CD45 (-ve markers) markers 
5.2.4.2 Cell morphology and spreading 
After seeding the cells are rounded in shape and scattered throughout the nanofibrous mat 
(Figure 5.29 (a) and (b)). But after 24 h, hMSCs are elongated with spread morphology and 
observed in colony (Figure 5.29 (c) and (d)). The spread morphology indicates the active cell 
proliferative potential of MSCs over nanofibrous scaffold. 
 
Figure 5.29: Temporal evaluation of hMSCs spreading on electrospun SF blend nanofibrous 
scaffolds (a) and (b) after 1 h (c) and (d) after 24 h of cell spreading by confocal and SEM 
analysis 
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5.2.4.3 Metabolic activity of MSCs 
The metabolic activity of MSCs on the scaffolds were examined qualitatively by fluorescence 
study and further quantified by MTT assay. Figure 5.30 (a-c) demonstrates the relative cellular 
metabolic activity of MSCs grown over B. mori, gelatin and SF blend scaffold under fluorescent 
microscopy after 3 days of culture using CMFDA dye. This is an excellent method for 
morphological observation of cellular viability and cytotoxicity. The overall signal in the field of 
observation was measured and the fluorescence intensity per cell was determined. It was 
observed that the cells proliferate in an increasing order over gelatin, B. mori and eri-tasar 
scaffold. However, cells grown over B. mori scaffold have a lower metabolic activity as the 
CMFDA signal per cell appears weaker than followed by gelatin and eri-tasar scaffold. This is in 
good agreement with the previous observation reported by Patra et al. in case of porous tasar 
(Antheraea  mylitta) SF scaffold [189].  
   
Figure 5.30: Fluorescence image using CMFDA dye showing the cell viability after 9 days on 
(a) B. mori (b) gelatin (c) SF blend (eri-tasar) 
A quantitative analysis of the metabolic activity of MSCs was assessed by MTT assay by 
culturing MSCs on gelatin, B. mori and eri-tasar nanofibrous scaffold. Figure 5.31 shows the 
relative cellular metabolic activity of MSCs after 3, 6, 9 days of culture. It has been observed that 
cellular metabolic activity is significantly higher in case of eri-tasar followed by gelatin and then 
B. mori scaffold. Thus both qualitative and quantitative observation confirmed that the cells 
grown over eri-tasar scaffold are metabolically superior to that of B. mori and gelatin scaffolds. 
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Figure 5.31: MTT assay of SF blend, gelatin and B. mori nanofibrous scaffold after 3, 6, 9 
days of culture. 
5.2.4.4 Cell proliferation 
Cell proliferation is the increase in number of MSCs because of cell growth and cell division. It 
is also a sensitive indicator of cellular stress as it requires intact cell structure and function. 
Further, the maintenance of undifferentiated proliferated cells depict that hMSCs produce 
adequate growth factors and adhesion molecules for its maintenance in scaffold [190].  
SEM  
SEM study was performed to assess the proliferation of hMSCs on the nanofibrous B. mori and 
eri-tasar scaffolds qualitatively by culturing MSCs for 7 and 14 days. The SEM images are 
shown in Figure 5.32 a (BM) & b(ET)  and Figure c (BM) & d(ET)  for 7 and 14days of culture 
respectively. Both scaffolds have shown to promote cellular proliferation as it is indicated by the 
well spreading of the cells over the scaffolds and aggregation of spindle shaped cells. The fibers 
are found to remain intact and initiation of mineralization is observed after 14 days. However, 
higher number of proliferated cells is observed with eri-tasar representing better cell supportive 
property of eri-tasar.  
Results and Discussion 
 
85 
 
  
  
Figure 5.32: SEM images showing proliferation of MSCs after 7 and 14 days of culture over 
SF blend (ET) and BM scaffolds 
DNA content estimation 
Further, a quantitative measurement of cell proliferation on the scaffolds was done by estimation 
of DNA content. The DNA content in MSCs was compared with the MSCs grown over B. mori 
and gelatin (as negative control) scaffolds. The result of MSCs proliferation after 7, 14 and 21 
days of cell culture is shown in Figure 5.33. It is observed that the rate of proliferation increases 
(increased DNA content) with time up to 21 days for all the cases. However, the rate was faster 
for the first 14 days representing the log phase and then a decline in rate is observed. The rate of 
proliferation of MSCs follows the trend eri-tasar > B. mori > gelatin for all the days of culture 
under study.  
(c) (d) 
(a) (b) 
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The percentage increase in rate of proliferation from day 7-21 on gelatin, B. mori and eri-tasar 
are 82%, 128% and 135% respectively whereas an increase in rate is found to be 4%, 6% and 9% 
from day 14-21. Furthermore, the amount of isolated DNA obtained with eri-tasar is 13% more 
than that of B. mori after 21 days. The high proliferation over eri-tasar nanofibrous scaffold than 
B. mori may be explained due to proper initiation of cell-scaffold interaction [191]. This study 
demonstrates that the superiority of eri-tasar over other scaffolds in terms of cell viability and 
proliferation ability of MSCs on the scaffolds. 
 
Figure 5.33: Rate of cellular proliferation in terms of DNA content estimation 
5.2.4.5 Cell adhesion 
Cell adhesive property is one of the most important criteria for selecting material to engineer 
tissue. Therefore in the present section, the cell adhesion property of eri-tasar scaffolds was 
assessed by confocal, TEM and flow cytometry analysis for cell attachment, expression of cell 
adhesive molecules (CD44 and CD29) and development of cellular outgrowth similar to 
lamellopodia. 
Cell attachment 
Nanofibrous scaffold prepared from gelatin is used as a negative control in vitro because of its 
poor adhesive property towards MSCs. The cell adhesion property was also compared with B. 
mori and gelatin scaffold. Passage 4 MSCs were allowed to attach for 12 h and 48 h on the 
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scaffold and then cell attachment on the scaffolds was evaluated by confocal microscopy. The 
cytoskeleton organization of the MSCs was demonstrated by phalloidin staining of the F-actin, 
counterstained with DAPI (nuclei) in Figure 5.34. Figure 5.34 (a, c, e) shows the distribution of 
MSCs after 12 h over gelatin, B. mori and eri-tasar scaffold. It was observed that the MSCs are 
scattered and feebly distributed over gelatin scaffold. B. mori shows comparatively more number 
of attached MSCs while maximum numbers of attached cells are observed on eri-tasar scaffold. 
The MSCs on gelatin scaffold has shown rounded morphology and less spreading nature even 
after 48 h. While that of B. mori and eri-tasar has elongated and well spreading in nature. They 
are observed to produce stress fiber like cytoskeleton after 12 h of post seeding (as observed 
through actin cytoskeleton orientation) and extensive cell-cell interaction and aggregation are 
observed after 48 h (d, f). MSCs over gelatin scaffold are without spread morphology and fail to 
stain strongly with phalloidin indicating lack of adequate actin polymerization even after 48 h 
(Figure 5.34 (b)). The few cells attached to gelatin scaffold surface were elongated and F-actin 
visible on its surface which indicate regional stress fibers. In contrast, after 48 h the MSCs over 
B. mori shows better polymerization of actin filament while over eri-tasar adequate and 
prominent polymerized actin has been observed. Thus the cell attachment property of MSCs 
follow the trend eri-tasar > B. mori > Gelatin. 
  
(a) (b) 
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Figure 5.34: Confocal microscopic images showing the attachment of MSCs after 12 and 48 h 
of seeding on gelatin (a, b), B. mori (c, d) and SF blend (eri-tasar) (e, f) respectively. MSCs 
cultures were stained for β actin (green) and DAPI (nuclei, blue). Scale bar: 100 μm. 
As indicated in Figure 5.35, the numbers of attached cells over eri-tasar are significantly higher 
than those of B. mori while gelatin shows poor cell attachment.  
(c) (d) 
(e) (f) 
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Figure 5.35: Quantitative estimation of MSCs attachment on gelatin, BM and ET scaffold.  
The enhanced cell attachment over eri-tasar may be attributed to high surface irregularity, 
roughness (observed through TEM micrograph of nanofibrous structure (Figure 5.9)) as well as 
presence of RGD epitope.  
Furthermore, it is a well-established fact that the adhesion of MSCs in a suitable matrix 
environment occurs through a network of dynamic contractile machinery which facilitates 
cellular motility with the formation of cell protrusions [192,193]. Figure 5.36 (a-e) showed the 
prominent development of outgrowths and cell processes similar to lamellopodia and figure 5.36 
(f) confirms the formation of lamellopodia through immunofluorescence study in eri-tasar 
scaffold. These structures are reported to be essential for cell spreading, in vitro polarization and 
acknowledged to participate in an active ongoing process such as absorption, adhesion, secretion, 
mechanotransduction as well as adaptation of MSCs to surrounding eri-tasar scaffold [194]. 
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Figure 5.36: TEM images showing the development of cellular outgrowth over SF blend 
nanofibrous scaffold confirming cell adhesion after 12 h of cell seeding. 
Expression of CD44 and Integrin beta 1 
MSCs express adhesion molecules or transmembrane receptors such as hyaluronan (CD44) and 
Integrin beta 1 (CD29) in context to their extracellular microenvironment. They are liable for 
signal transduction and modulate interaction between F-actin in cytoskeleton and components of 
ECM [195,196]. Figure 5.37 shows the immune fluorescence analysis of expression of CD44 and 
integrin beta 1 on MSCs grown over SF blend nanofibrous mat. These transmembrane receptors 
are clearly visible over the membrane as green fluorescence. The quantitative degrees of 
expression of hyaluronan and integrin beta 1 were estimated through FACS as observed in 
Figure 5.37 (a) and (b). The study demonstrates a substantially higher amount of integrin beta 1 
and CD44 expressions over MSCs cultured on eri-tasar nanofibrous mat after 24 h of cell 
seeding. The expression of above receptors are lower in B. mori while gelatin shows minimum 
expression (-ve control) and fibronectin shows (+ve control) maximum expression of the above 
markers. 
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Figure 5.37: Expression of CD29 (anti-integrin beta 1 Immuno fluorescence) and CD44 
(hyaluronane receptors) after 24 h of MSCs seeding onto SFnanofibrous scaffold as observed 
under Confocal microscope. 
These receptors are also reported to act as mechanotransducers to detect change in matrix 
variation and polarize MSCs towards growth, proliferation, morphogenesis, integrated cellular 
response, wound healing and differentiation allowing aggregation of proteoglycans [38,39]. 
Additionally, focal adhesions which is an essential step for the structural linkage between ECM 
and cytoskeleton with the formation of stress fibers [197] involves beta 1 integrin engagement 
and recruitment of protein for stabilization of actin cytoskeleton [198]. Furthermore, CD44 
promotes integrin activation as well as bind to extra-cellular hyaluronic acid that exhibits various 
biological functions such as cell adhesion, matrix assembly, endocytosis, and cell signaling 
[199]. 
As it is observed in figure, the higher expression of adhesion molecules such as CD44 and beta 1 
integrin over SF blend eri-tasar nanofibrous scaffold (Figure 5.38) ensures enhanced 
adhesiveness and proliferation functionality of MSCs which implicated the survivability of tissue 
graft by reducing the inflammatory reaction and immune activation at the site of injury [200]. 
Thus it reduces the use of immunosuppressant and anti-inflammatory drugs. Proper adhesiveness 
of tissue graft with surrounding tissue reduces the chance of scar tissue formation (internal scar 
tissue are very difficult to remove) and increases the colony forming activity of MSCs so that 
survival rate and efficiency of natural tissue regeneration is likely to be enhanced. 
(a) (b) 
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Figure 5.38: Flow cytometry analysis for quantitative expression of (a) CD44 and (b) CD29 of 
MSCs over nanofibrous scaffold after 24 h of seeding 
5.2.3.6 Osteogenic differentiation 
ALP activity of hMSCs on SF scaffolds 
ALP cleaves organic phosphate ester and is a key component which has a role in the formation 
of apatite CaP [201]. It is an early indicator of immature osteoblast activity with a commitment 
to osteoblast phenotype [202]. ALP activity of hMSCs on the nanofibrous scaffolds such as 
gelatin, B. mori, and eri-tasar have been observed on 7, 14 and 21 days of culture in osteogenic 
media and the data are plotted in Figure 5.39. The figure indicates substantially higher amounts 
of ALP on eri-tasar after 14 days of MSCs culture which steadily increases towards 21 days. 
Elevated levels of ALP are observed during the initial phase of mineralization i.e. about 14 days 
of culture [203]. The ALP activity is significantly higher (p<0.01) on eri-tasar SF blend (ET) 
scaffold as compared to B. mori on day 7, 14, 21.  
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Figure 5.39: Expression of ALP with respect to culture time and type of scaffold  
Glycosaminoglycan (GAG) estimation   
The GAG production is an indication of differentiation towards a specific lineage. The three 
types of scaffolds (gelatin, B. mori and eri-tasar) studied show small amounts of secreted GAG 
into the scaffold and medium even after 28 days (Figure 5.40). The difference in GAG secretion 
between B. mori and eri-tasar scaffolds is statistically insignificant. GAG secretion is 
significantly low with gelatin after 28 days of culture in osteogenic media as compared to the 
other two. GAGs are a trivial component of organic bone ECM (less than 1%). They are thought 
to bind and accumulate a number of distinct proteins including growth factors and cytokines, 
improve and stabilize the presentation to their relevant receptors and protect them from 
proteolytic degradation [204, 205]. GAG deposition of 25 μg/0.6 cm2 scaffold in MSCs seeded 
constructs containing osteodifferentiation media was higher than that of controls even after 28 
days confirming the superior osteogenic potential of eri-tasar scaffold.  
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Figure 5.40: GAG assay through biochemical estimation (GAG deposited over scaffold + GAG 
secreted into media) on day 1 and 28 of culture in osteogenic media. 
Mineralization of hMSCs on scaffolds  
Figure 5.41 (a) corresponds to the image of HAp crystal attached to individual nanofiber after 28 
days of osteogenic stimulation taken by HR-TEM. SEM images of the mineralized matrix upon 
osteogenic stimulation are shown in Figure 5.41 (b) and (c) whereas Figure 5.41 (d) provides the 
elemental analysis of the white crystal deposits by EDX which shows the Ca:P intensity  ratio 
1.6.  
  
(a) (b) 
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Figure 5.41: Osteogenic differentiation induced through osteogenic differentiation media and 
mineralization is observed at 28 days was analyzed using (a) TEM showing clearly visible 
mineral nanocrystals attached to nanofiber (b) and (c) Overcrowded cell matrix with white 
crystals of calcium phosphate in the ratio 1.6 as obtained from EDX analysis (d). 
One of the common way to identify HAp is by measuring the ratio of calcium and phosphate. 
The Ca:P of phase pure HAp is 1.67 while that of human bone it varies between 1.5-1.7 (healthy 
human bone 1.63). The variations of this ratio are owing to age, anatomical location and disease 
condition [206]. The deposition of this precursor phase in biomineralization processes of blended 
SF nanofibrous scaffold explains the suitability of hMSCs towards osteospecific lineages. This 
shows the competence of scaffold for osteoinductive property. 
The corresponding images of MSCs seeded eri-tasar scaffold constructs treated with alizarin red 
are shown in Figure 5.42 (c). The Figure 5.42 (a) and (b) indicate the  qualitative results from 
alizarin red staining of cellular constructs for nanofibrous scaffold derived from gelatin and B. 
mori silk respectively. Their quantitative values are given in Figure 5.42 (d). The result indicates 
the superiority of eri-tasar scaffold over B. mori and gelatin towards osteogenic differentiation 
which is similar to predictions by Binulal et al [207].   
(d) (c) 
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Figure 5.42: Evaluation of mineralization of hMSCs on (a) gelatin (b) BM and (c) SF blend 
scaffolds using alizarin red staining under fluorescence microscope. Substantially higher 
mineralization is observed based on high fluorescence intensity. 
 
Figure 5.43: Quantitative estimation of relative amount of mineralization on gelatin, BM and 
ET nanofibrous scaffold. 
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RUNX2 expression 
The osteogenic differentiations of MSCs on the scaffold were further assessed by qualitative 
analysis of RUNX protein (Figure 5.44). RUNX2 is an early marker of osteoblast differentiation 
[208]. RUNX2 protein is localized in nuclei of osteoblast [139]. Immunochemistry after 7, 14, 21 
days of culture shows qualitative expression of RUNX2. After 14 days, the activity shows a 
declining phase towards 21 days of activity in both B. mori and eri-tasar scaffold. The overall 
signal in the field of observation was calculated and the fluorescence intensity per cell was 
measured. The observation demonstrated that fluorescence signal intensity per cell is stronger 
after 14 days as compared to the signal intensity after 21 and 7 days. On the other hand, the 
observed intensity per field (area of observation) in case of eri-tasar is higher than B. mori which 
may be attributed to the presence of more number of RUNX2 expressed cell as well as higher 
fluorescence intensity per cell present over eri-tasar.  
  
  
(c) (d) 
(a) (b) 
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Figure 5.44: Subcellular localization of RUNX2 protein through immunofluorescence 
staining by FITC conjugated secondary antibody counter stained with HOEST after 7, 14 and 
21 days of culture on B. mori (a-c) and SF blend (d-f). 
Osteocalcein activity 
Osteocalcin is a late stage marker for complete osteogenic differentiation [209]. Initially, their 
expressions are observed to be very low and substantial increase in expression occurs after 14 
days of culture. Figure 5.45 shows the expression of osteocalcin over differentiated MSCs grown 
over gelatin, B. mori and eri-tasar after 14 and 21 days of culture. The overall fluorescence signal 
intensity in the field of observation was measured and per cell was determined. The observation 
found that expression of osteocalcin depends on time as well as type of scaffold. The overall 
field intensity is less in case of gelatin and B. mori as compared to eri-tasar after 21 days. Even 
after 14 days, osteocalcein expression over differentiated MSCs is better than those of gelatin 
and B. mori. Additionally, the fluorescence intensity per cell over eri-tasar found to be higher, 
although there is more number of cells per field in gelatin and B. mori scaffold. 
(e) (f) 
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Figure 5.45: Osteocalcein staining for bone phenotype on gelatin, B. mori and SF blend 
nanofibrous scaffold after 14 and 21 days of culture (a) and (d) hMSCs over gelatin (b) and 
(e) hMSCs over B. mori (c) and (f) hMSCs over eri-tasar nanofibrous scaffold. 
(c) 
(b) 
(e) 
(d) 
(f) 
(a) 
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Further quantitative analysis of osteocalcin after 7, 14 and 21 days of culture (Figure 5.46) has 
supported the previous finding and stipulated its better osteogenic behavior. As indicated in 
figure, the osteocalcein activity is remarkably higher than the other two scaffolds after 21 days of 
culture with gelatin showing lowest osteocalcein activity. 
 
Figure 5.46: Quantitative expression of osteocalcin as measured in hMSCs cultured over 
gelatin, B. mori, SF blend scaffold. 
Together with the hMSCs differentiation into osteogenic lineages was confirmed by ALP 
activity, RUNX2 expression, matrix mineralization and osteocalcin expression. Mineralization 
and osteocalcin expression are considered as formation of mature osteocytes and our results 
showed that hMSCs on nanofibrous scaffold are differentiated and mineralized the matrix upon 
stimulation with osteogenic media. The mineralized crystals deposited over nanofibers are in 
nano scale as found in natural bone and clearly visualized through HRTEM and as aggregated 
particles through SEM. EDX analysis demonstrated the Ca:P ratio of the mineral deposits was 
the same as that of hydroxyapatite [210]. ALP is expressed earlier in osteoblast cells and 
osteocalcin is expressed in fully differentiated osteoblasts. RUNX2 is expressed during its 
transition from immature osteoblast to mature osteoblasts. The above study suggests that blended 
eri-tasar nanofibrous scaffold provides an in vivo like in vitro environment and therefore the 
cells respond naturally. Differentiations of hMSCs into mature osteoblast-like cells were further 
confirmed by expression of osteocalcin where mature osteoblasts undergo mineralization [211]. 
The higher response of blended eri tasar nanofibrous scaffold compared to B. mori SF 
Results and Discussion 
 
101 
 
nanofibrous scaffold suggests the greater osteogenic potential for this system. Overall, these 
studies suggest that eri-tasar composite silk nanofibrous scaffold offers significant osteogenic 
potential warranting further study towards bone tissue graft development. 
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PART III 
Development of SF/nHAp composite scaffold         
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Several studies have suggested that the use of HAp, Ca10(PO4)6(OH)2 (Ca:P-1.67), the chief 
constituent of bone promote osteogenic property of scaffold material [212,213]. Therefore, a 
number of researchers have attempted to develop composite scaffolds using natural polymers 
such as SF, collagen, gelatin, chitosan and HAp. Most of these composite scaffolds with porous 
and fibrous structures were prepared by mechanical mixing of desired amount of HAp with 
natural polymers. However, the major drawback of this process is that the mineral phase does not 
form in situ and only simply adheres to the surface of polymer fibers that provides poor 
interaction between them due to the formation of agglomerates [214]. To overcome this problem 
an advanced method called direct mineralization involving the precipitation of mineral phase 
within the polymer solution has been developed as reported [215, 216]. Therefore, in the present 
study, research work focuses on the development of SF/nHAp composite scaffold with improved 
osteogenic characteristics by precipitating nHAp over the developed eri-tasar SF blend 
nanofibers following direct mineralization. The results and discussion are presented here. 
5.3.1 Characterization of SF/nHAp scaffold 
5.3.1.1 Morphological characterization  
Figure 5.47 shows the precipitation of nHAp crystals over blended eri-tasar SF nanofibrous 
scaffold after three cycles of treatments. The nHAp are deposited in the agglomerated form as 
can be seen from SEM images (a) on close observation it was found that the particles not only 
deposited on the surface of the fibers but also on the inside of fibers. They also deposited on the 
fibers below the surface. The particles were of different shapes and sizes in 30-50 nm. The 
attachment of the nHAp particle to the fibers is further seen under TEM. Figure 5.47 (b & c) 
clearly shows that the attached nHAp crystals are growing randomly on the SF nanofibers. The 
sizes of the nHAp particles are not uniform in shape but resemble crystalline structure. 
Furthermore, the transparent portions of the deposited HAp particles resemble to be crystalline 
while the dark and opaque portion is the amorphous in nature. The crystallinity of the nHap was 
further confirmed by XRD analysis. EDX analysis revealed that Ca and P ions are in the ratio of 
1.6 confirming the deposition of nHAp over SF nanofibers. Thus, mineralization of nanofibrous 
scaffold with HAp is expected to provide a favorable environment for bone tissue engineering. 
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Figure 5.47: (a) SEM (b) and (c) TEM images of nHAp particles deposited over blended eri-
tasar SF  nanofibers (d) EDX analysis depicts the presence of Ca and P ions on nanofibers. 
5.3.1.2 Structural analysis 
XRD  
Phase analysis of SF/nHAp nanofibrous scaffold was carried out by XRD as shown in Figure 
5.48. As it is indicated, the diffraction pattern shows the characteristic peaks of α-helix structure 
at 21
0(2θ) and β-structure at 29.54(2θ) which confirms the semicrystalline nature of the fiber. A 
peak at 39.26
0 
corresponds to the characteristic peak of HAp. Thus mineralization of SF was 
proved to be occuring due to the precipitation of HAp over the developed SF nanofibers 
[94,161,217]. Furthermore, from the XRD study it can be concluded that HAp produced by 
surface precipitation method is semicrystalline in nature. 
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Figure 5.48: XRD of HAp precipitated over SF blend nanofibrous scaffold. 
FTIR 
Figure 5.49 demonstrates the interaction of functional groups present in SF/nHAp scaffold. The 
absorption band at 697, 612 and 563 cm
-1
 in Figure 5.48 corresponds to O-P-O bending in the 
mineralized SF scaffold which indicates the presence of nHAp over nanofibers. The absorption 
band at 958 cm
-1 
corresponds to o-p-o stretching vibration indicating the presence of PO4
3- 
group. 
The C=O stretching vibration of amide I at 1658 cm
-1
 and N-H bending of amide II band at 
1524-1530 cm
-1
 for both eri-tasar SF and mineralized SF/nHAp are observed from FT-IR 
spectra. 
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Figure 5.49: FT-IR analysis of SF/nHAp nanofibrous scaffold  
On close observation of FT-IR spectra (Figure 5.49), it has been observed that the intensity of 
two amide peaks present in nHAp deposited on SF nanofibers were repressed severely as 
compared to pure SF blend scaffold. This may be due to the deposition of HAp over SF 
nanofibers which can be explained through interaction between Ca
2+
 ions of HAp and C=O 
bonds in amino acids of scaffold [218]. Consequently, HAp crystals precipitated on the surfaces 
of SF would provide nucleation site for CaP crystals [219]. 
5.3.1.3 Thermal analysis 
Figure 5.50 shows TGA analysis carried out with SF/nHAp composite scaffold. The observed 
weight loss at 100
0
C is probably due to water evaporation present in the fiber without being 
chemically attached. In comparison, the weight loss is found to be varying between SF and 
SF/nHAp scaffold in the range 6-7% (Figure 5.50), higher weight loss observed with pure SF 
scaffold (10-12% reported earlier). The mineralized SF composite scaffold has started 
decomposition above 350
0
C and its residual weight loss is about 15%. However, a sharp 
decomposition with weight loss about 30-35% is shown at about 375
0
C. It is observed that eri-
tasar SF blend/nHAp has started degradation at higher temperature than pure eri-tasar blend SF 
due to present of inorganic salt HAp [94]. 
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Figure 5.50: TGA of SF/nHAp nanofibrous scaffold 
5.3.1.4 Mechanical properties 
It has been reported that HAp scaﬀolds possess poor mechanical strength, particularly low 
strength and brittleness limit their applications to tissue implants [220]. Therefore, the effect of 
mineralization using HAp on the tensile strength of SF scaffold was investigated by analyzing 
the stress-strain curve (Figure 5.51) of the developed scaffold.  Four different nanofibrous sheets 
of identical thickness prepared in different batches were represented by different color codes as 
depicted in figure. A drastic reduction in ultimate tensile strength and %elongation of SF blend 
scaffold is observed which is due to the HAp deposition. The corresponding ultimate tensile 
strength and % extension of HAp mineralized SF scaffolds are measured to be 0.392MPa and 
2.895% respectively whereas these values for pure ET scaffold are 1.83 MPa and 7.756% 
(Figure 5.15). Similar results are also reported for PCL/HAp and PLA /HAp electrospun 
scaffolds [221, 222]. Additionally, it has been observed that the ductile property of SF/nHAp has 
been reduced which is evident from the nature of graph and measured %extension of the 
scaffold. The decrease in UTS may be attributed to the restricted free moments of nanofibers 
resulting due to the presence of nHAp. The deposition of HAp makes nanofibrous matrix more 
stiff and less plastic because of hard inorganic phase and high charge density of HAp [221] 
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However, the developed SF/nHAp scaffolds still have the desired tensile strength and % 
elongation required for its application in non-load bearing bone tissue regeneration.    
 
Figure 5.51: Stress strain curve of HAp deposited SF nanofibrous blend scaffold.  
Additionally, it has been observed that the ductile property of SF/nHAp has been reduced which 
can be understood from the nature of graph and extension % of scaffold. However, the developed 
SF/nHAp scaffolds still have the desired tensile strength required for its application in non-load 
bearing bone tissue engineering.    
5.3.1.5 Water uptake capacity and measured contact angle 
Figure 5.52 demonstrates a comparative study of % water uptake observed with SF and 
SF/nHAp scaffolds. The % water uptake and swelling ratio of SF/nHAp nanofibrous scaffold are 
measured as 79% and 0.83 after 96 h of treatment in PBS.  
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Figure 5.52: Water uptake capacity of SF blend and SF/nHAp scaffold after 96 h of treatment 
in SBF. 
Thus, water uptake capacity and swelling index of SF/nHAp composite scaffold are found to be 
higher than pure SF blend scaffold (Figure 5.52). The higher water uptake capacity reflects 
higher hydrophilicity characteristic of composite scaffold. This was further confirmed by water 
contact angle measurement. The measured contact angle is 53.4±2.7
0
 which is lower than SF 
blend scaffold. Therefore, the developed composite scaffold has shown enhanced surface 
property that is favorable for bone tissue engineering application.  
5.3.1.6 Bioactivity study 
The ability of a material to deposit HAp crystal over its surface determines its osteogenic 
property. Figure 5.53 shows SEM images of mineralized SF scaffold after 14 days of treatment 
in SBF. nHAp crystals are observed to cover the surface of scaffold that proves the suitability of 
the composite scaffold for bone tissue regeneration. 
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Figure 5.53: Bioactivity of SF blend/nHAp scaffold by SEM after 14 days treatment in SBF 
5.3.2 In vitro cell culture study 
5.3.2.1 Morphology and attachment of MSCs 
As explained in previous chapter, one of the selection criteria of tissue engineered material is the 
attachment profile of MSCs on scaffold. Several studies have reported that surface precipitation 
of apatite crystals provides certain degree of toxicity in cell attachment [220]. Therefore, it is 
important to verify whether the deposition of nHAp has any toxic effect on MSCs attached to the 
developed composite scaffold. After 48 h of culture, MSCs were found to attach on the 
nanofibrous composite scaffolds with elongated and well-spread morphology as evident from 
confocal images (Figure 5.54). This suggests that composite SF/nHAp scaffold is a good 
substrate for growth and proliferation without significant toxic effect. 
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Figure 5.54: Confocal Laser Scanning Microscope images of MSCs attachment over 
SF/nHAp nanofibrous scaffold. MSC cultures were stained for β-actin (Phalloidin 
Cytoskeleton-green) and DAPI (nuclei, blue) scale bar 25 μm. 
5.3.2.2 Metabolic activity of MSCs 
Figure 5.55 (a-b) demonstrate relative cellular metabolic activity of hMSCs grown over SF and 
SF/nHAp stained with CMFDA dye under fluorescent microscope after 72 h of culture. It has 
been observed that the fluorescence intensity per cell was slightly higher in case of pure SF blend 
scaffold. However, the number of cell under the area of observation in SF blend scaffold is 
higher than that of SF/nHAp scaffold. The results are further quantified by MTT assay. 
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The metabolic activity of a cell generally takes place in G1 phase which is the pre-DNA 
synthesis period. It determines the ability of a cell to proceed further in the cell cycle [221]. MTT 
assay was performed to assess cellular metabolic activity of hMSCs over pure SF blend and 
SF/nHAp scaffolds based on 3, 5, 7 and 10 days of hMSCs culture as shown in Figure 5.56. 
Slightly higher cellular metabolic activity is observed with SF blend scaffold than SF/nHAp 
scaffold. The corresponding cell viability values are steadily increasing up to 10 days in both the 
cases. Slightly lower metabolic activity observed with the composite scaffold bears no statistical 
significance claiming the SF/nHAp scaffold of comparable activity.  
  
Figure 5.55: Fluorescence microscopic images (CMFDA dye image) showing cell viability and 
proliferation after 5 days on (a) SF blend and (b) SF/nHAp composite scaffold. 
 
Figure 5.56: MTT assay for cell viability after 3, 5, 7 and 10 days of culture on SF/nHAp 
composite scaffold 
(a) (b) 
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5.3.2.3 Cell Proliferation  
The proliferations of MSCs on the scaffolds were observed by SEM after 7 and 14 days of 
culture on and SF/nHAp scaffold to investigate the effect of deposited nHAp on the cell 
proliferation. Figure 5.57 (a) and (c) show the proliferation of MSCs after 7 and 14 days of 
seeding on ET, whereas (b) and (d) over ET/nHAp.. Both types of scaffolds show extensive 
proliferation and deposition of secretary extracellular matrix substances. The extensive 
proliferation and deposition make it difficult to visualize the fibrous morphology. As indicated in 
Figure 5.57, cell proliferation is progressively increased with culture period up to 14 days and 
then the rate follows a decline in trend which is the case for both pure and HAp deposited 
scaffold. Furthermore, the proliferation rate of MSCs on SF/nHAp and control (SF) is found to 
be comparable in nature. SEM study has further indicated that proliferated cells are aggregated 
and overcrowded with substantial deposition of secretory products in both types of scaffolds with 
a little higher deposition in SF/nHAp composite scaffold.   
Quantitative estimation of cellular proliferation over pure SF blend and SF/nHAp scaffolds was 
done using Alamar blue assay. Cellular proliferation over SF blend scaffold is found to be higher 
than that of SF/nHAp. The rate of proliferation is found to increase with the increase in culture 
period up to 14 days followed by a decline in the growth rate beyond this period as observed in 
Figure 5.58. However, this slightly higher rate of cell proliferation over SF/nHAp may not differ 
much to affect differentiation process. 
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Figure 5.57: SEM images show cellular proliferation after 7 and 14 days of culture over SF 
blend and SF/nHAp composite scaffolds. 
 
 
Figure 5.58: Alamar blue assay for hMSC proliferation on blended SF blend and SF/nHAp 
composite scaffolds over 28 days of cell culture 
5.3.2.4 Cell adhesion molecules: CD44 and CD29 (Beta 1 integrin receptors) 
As it is observed in the previous chapter, the expression of CD44 and CD29 is an important 
factor in deciding the suitability of outer matrix environment in cell adhesion processes. 
(c) (d) 
Results and Discussion 
 
115 
 
Therefore, the expression of these markers over MSCs on SF/nHAp scaffold was estimated by 
flow cytometry analysis depicted in Figure 5.59. Both CD29 and CD44 expressions of MSCs 
were observed in all the scaffolds as well as control with a varying degree of expression. MSCs 
grown over gelatin scaffold were used as negative control. 12% CD29 and 38% CD44 
expressions are achieved after 24 h of MSCs grown over the control. However, the pure SF blend 
scaffold has shown maximum expression of CD44 (89%) and CD29 (94%). A significant 
decrease in expression of CD44 (67%) and CD29 (71%) is observed with SF/nHAp scaffold. The 
reduction in expression may be explained as the reduction in availability of RGD ligand due to 
surface covered by nHAp. However, their expression level is adequate to drive the cell for 
proliferation and differentiation.  
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Figure 5.59: Expression of cell adhesion molecules CD 44 and CD 29 (beta 1 integrin) (a) and 
(b) –ve control, (c) and (d) SF blend scaffold, (e) and (f) SF/nHAp composite scaffold.  
5.3.2.6 Osteogenic differentiation of MSCs 
The MSCs can differentiate into various cell types such as osteogenic and chondrogenic lineages 
where the matrix elasticity plays an important role. In contrast, a high density of cells may affect 
differentiation process even if the elastic modulus of matrix is favorable for osteogenic 
differentiation [222]. Therefore, the suitability of scaffold to differentiate into osteogenic 
lineages has been studied through the expression of different markers as well as the study of 
mineralization.  
ALP assay  
Figure 5.60 demonstrates ALP activity of MSCs over gelatin, SF blend, SF/nHAp composite 
scaffolds after 7, 14 and 21 days of culture. It has been observed that the ALP activity is 
significantly higher over SF and SF/nHAp as compared to gelatin. The absorption intensity 
which is a measure of ALP activity shows 115% increase in absorption during the period of 7-14 
days while after 21 days it shows an increase of 128%. Similarly, the change in absorption 
intensity after 14 days for SF and SF/nHAp is 160% and 185%, while an increase of 190% and 
205% is noticed after 21 days. Thus the rate of ALP production is higher during 7-14 days than 
the period between 14-21 days. This indicates that major change in osteogenic property occurs 
between the 7-14 days of growth. Furthermore, the ALP activity is significantly higher over 
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SF/nHAp as compared to SF scaffold after 21 days. Thus, the study suggests an enhanced 
osteogenic potential of SF/nHAp composite scaffold due to nHAp deposition. 
 
Figure 5.60: ALP activity of hMSCs on gelatin, SF blend and SF/nHAp composite scaffolds 
after 7, 14 and 21 days of culture 
Mineralization of hMSCs on SF/nHAp scaffolds  
Immunofluorescence study by alizarin red staining in Figure 5.61 (a-c) clearly indicates 
significantly higher amount of mineralization over SF blend/nHAp composite scaffold compared 
to other scaffolds used in this study after 28 days of culture of MSCs. The quantitative estimation 
of alizarin red assay (Figure 5.61 (d)) also confirms similar results. This shows the highest 
mineralization activity of differentiated MSCs over HAp precipitated nanofibrous scaffold 
representing the higher osteogenic potential of SF/nHAp compared to pure SF blend nanofibrous 
scaffold.  
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Figure 5.61: Alizarin red assay for mineralization of hMSCs on (a) gelatin (b) SF blend/ (c) 
SF/nHAp composite scaffolds and (d) their quantitative estimation 
The higher osteogenic potential of SF/nHAp scaffold, may be explained as follows-the 
osteoblast-like cells express calcium receptors [223] and therefore, reside in bone matrix 
consisting of HAp crystals playing a significant role in osteogenic differentiation. It is reported 
that the adsorption of proteins and other biologically active molecules to HAp is different than 
pure SF blend. These proteins and biologically active molecules may mediate the interaction 
between cells and scaffolds resulting in a difference in osteogenic potential of the scaffolds 
[224]. 
Morphological study of differentiated MSCs  
Figure 5.62 shows the differentiated MSCs cultured over different nanofibrous matrices for 21 
and 28 days of culture. Immunefluorescence study demonstrated the differentiated osteoblast 
(osteocytes) over gelatin (a & d), SF/nHAp (b & e), SF blend (c & f) after 21 and 28 days 
respectively. Osteocyte count confirmed that SF/nHAp scaffolds possess maximum number of 
osteocytes as compared to SF scaffold showing the osteogenic superiority of SF/nHAp scaffold.  
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Figure 5.62: Fluorescence microscopy images of differentiated MSCs over (a) & (d) gelatin, 
(b) & (e) SF/nHAp composite (c) & (f) SF blend scaffolds after 21 and 28 days of treatment 
with osteogenic medium. The differentiated MSCs show osteocyte like morphology 
Together with the mineralized nanofibrous SF blend scaffold (SF/nHAp) has shown enhanced 
osteogenic differentiation ability of hMSCs derived from umbilical cord blood. Thus, it is proved 
that the SF/nHAp composite scaffold seeded with hMSCs will be useful to provide tissue 
engineered construct for repairing various bone defects and diseases. 
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In recent years bone tissue engineering has emerged as an alternative but most promising 
approach for repairing diseased or damaged bone tissue. The design and fabrication of a 
functional 3D scaffold from a variety of biopolymers that can mimic the porous structure and 
extracellular matrix function of bone is one of the key challenges in bone tissue engineering.    
SF derived from silk cocoon is considered as a potential biopolymer because of its high 
mechanical strength, desired surface and biological property. So far SF derived from B. Mori has 
been widely used for research by the scientists worldwide. However, B. mori SF lacks in cell 
supportive property because of its low hydrophilicity and RGD content that limit their use in 
tissue engineering. So effort must be given to obtain SF with superior surface property from 
other varieties of silk cocoons. It is further evident that a single biomaterial may not possess all 
the desired properties of scaffold and thus there is need for the development of a polymer blend 
and/or composite material with an appropriate composition from suitable biopolymers and other 
biomaterials. In this context, nHAp is reported to be an attractive component for developing 
polymer composite for bone tissue regeneration. 
Besides material properties, structural characteristics of the scaffold is an another important 
aspect as the macroporous feature of scaffold cannot exactly mimic the dimension scale of the 
ECM and as a result most of the scaffolds do not recapitulate the cell microenvironment for the 
proper proliferation, differentiation and neo tissue formation. In this context, artificial ECM 
made from polymeric nanofibers is considered as the most favorable feature for tissue 
regeneration because nanofibers have more resemblance with body tissue that can mimic ECM 
to a greater extent. Keeping the above issue, the main aim of this dissertation work was to 
develop a potential SF biopolymer and its composites (using nHAp) with better surface property, 
desired mechanical and biological properties for its use in bone tissue engineering.  
The most encouraging results achieved from this research are summarized as follows: 
i. In this phase of research, an attempt has been made to explore and develop SF biopolymers 
from two locally grown silk cocoons namely eri (P. ricini) and tasar (A. myilitta). First of all, 
SFs from both varieties of silk cocoons were extracted by standard degumming method and 
lyophilized. Then a suitable solvent system was selected based on the solubility and 
spinnability of silk fibroins and a spinnable SF blend solution with optimum blend ratio of 
eri:tasar 70:30 (w/w) was prepared using the selected solvent system with composition 
Summary and Conclusion 
 
122 
 
choloform:formic acid of 40:60 (v/v).  Finally, randomly oriented SF blend nanofibers were 
generated by electrospinning method and characterized. SF blend solution 8% w/v was found 
to be the most favourable concentration for nanofiber formation. The average diameter of 
nanofiber is 350 nm, the range being 300-500 nm. 
ii. The second phase of research work includes the fabrication and characterization of 3D 
nanofibrous scaffold from spinnable SF blend solution which was developed in the phase I. 
The nanofibrous scaffold of thickness 300 µm was prepared by electrospinning of SF blend 
solution. The average pore size and porosity of the scaffold were measured as 2-6 µm and 
76±5% respectively. The ultimate tensile strength and % elongation of the scaffold are 1.76 
MPa and 7.776%. The scaffold possesses desirable surface property as assessed by swelling 
and contact angle measurements. The scaffold is proved to be suitable for not-load bearing 
bone tissue regeneration based on the above physicochemical characterization. 
iii. In this phase, the degradation mechanism of electro spun SF nanofibrous mat was studied. It 
has been found that the amorphous region containing hydrophilic amino acid with bulky side 
chain were first degraded resulting release of stable crystal blocks which has been removed 
from the solution without being degraded. Further it has been observed that besides β-sheet 
content hydrophilic amino acid content as well as available nano structures (nanofibrils) play 
a dominant role in degradation of silk fibroin nanofibers. Based on this mechanism, SF with 
more controllable degradation behavior can be established. 
iv. In this part of thesis work, the developed SF scaffolds were further characterized for their cell 
supportive property by in vitro cell culture study. The scaffold has shown excellent cell 
attachment, cell proliferation and cellular metabolic activity. The scaffold has further 
exhibited its osteoinductive property as confirmed by ALP activity, biomineralisation assay, 
osteocalcein and RUNX2 expression representing the suitability of the scaffold for bone 
tissue engineering. The scaffold has also shown better surface and osteoductive property than 
the SF scaffold derived from most widely used B. Mori silk. 
In this phase, the osteogenic property of the developed SF blend scaffold was further improved 
by the deposition of nHAp on the surface of nanofibers to make the scaffold more potential for 
bone tissue engineering application. The HAp with 30-50 nm size was deposited on the scaffold 
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by surface precipitation method. Similar to SF blend scaffold, the composite scaffold was 
characterized for surface, mechanical and biological property and the results were compared with 
the results obtained with pure SF blend scaffold. It has been demonstrated that the developed 
composite scaffold has shown improved surface property and osteogenic differentiation ability as 
compared to SF blend as well as the widely used SF scaffold derived from B. mori. Overall, in 
this study a novel 3D electrospun nanofibrous scaffold has been developed from SF blend that 
was derived from two locally grown silk cocoons such as eri and Tasar. The surface and 
osteoinductive property of the scaffolds were further improved by nHAp deposition and thus 
SF/HAp scaffold were developed.  In conclusion, the results suggest that the developed SF blend 
derived from eri and tasar can be used as a base polymeric scaffold material for various tissue 
engineering applications including bone tissue regeneration. Further, SF/nHAp nanostructure 
developed in this study can pave the way to provide a promising scaffold exclusively for bone 
tissue engineering in future. 
Future work 
The developed eri-tasar scaffold can be further modified for proper vascularization. 3D 
designing of the scaffold with different geometry can be done by adopting layer-by-layer 
deposition method. The prepared nanofibrous scaffold can be further coated with different 
bioactive molecules to develop smart material with improved property for bone tissue 
engineering application. Further, in vivo preclinical trial may be given for biocompatibility 
study. 
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